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Abstract 
ALISON FAY WAGNER:  Effects of Heroin on Sickness Behavior and 
Proinflammatory Mediators in Associated Brain Regions 
(Under the direction of Donald T. Lysle, Ph.D.) 
 
Proinflammatory mediators in the brain are associated with a constellation of 
adaptive behaviors known as sickness behaviors.  Although many studies have 
confirmed peripheral immunosuppressive effects of opiates, none have demonstrated 
effects of heroin or any other opiate on immune responses within the central nervous 
system.  The following experiments examined the effects of heroin on brain 
proinflammatory mediators alone and during an immune challenge, and the effects that 
heroin has on sickness behaviors and proinflammatory mediators in associated brain 
regions. 
Experiments in Chapter 2 established that heroin produces a reliable, short-term 
hyperthermia that is not reversed by pre-treatment of indomethacin, nor does it correlate 
with increased proinflammatory mediators in the hypothalamus, the area of the brain 
most associated with temperature changes.  However, we did show that in the presence 
of an immune challenge (lipopolysaccharide, LPS), heroin appeared to have a 
suppressive effect on some proinflammatory mediators 90 minutes after treatment.
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In Chapter 3, we further investigated these findings and examined both LPS-
induced fever response and increased proinflammatory mediators in the 
hypothalamus, and determined that heroin has a suppressive effect on all 
proinflammatory mediators measured.  In addition to the proinflammatory mediator 
suppression, heroin also attenuated fever production induced by LPS.   
In Chapter 4, we examined the effects of heroin on LPS-induced 
proinflammatory mediators in the hippocampus, a region associated with behavioral 
depression.  As in the hypothalamus, the hippocampus exhibited suppressed 
proinflammatory mediators when heroin treatment occurred concurrently with LPS 
treatment, although the hippocampus selectively showed these effects in interleukin-
6 (IL-6) and tumor necrosis factor-α (TNF-α).  Additionally, heroin treatment 
diminished behavioral depression induced by LPS. 
Taken together, these studies indicated that although heroin produced 
hyperthermia, heroin treatment does not acutely elevate proinflammatory mediators 
in the brain (Chapter 2), and when it is given in the presence of LPS, heroin has an 
immunosuppressive effect on both production of proinflammatory mediators and 
sickness behaviors (Chapters 3 and 4).  Overall, these experiments demonstrate 
that heroin suppresses immune responses in the brain that are normally key parts of 
the process of producing adaptive sickness behaviors.  
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Chapter 1 
General Introduction 
 
Overview 
 It has become increasingly apparent that immune cells and their products in 
the central nervous system (CNS) are essential to a number of immunologically 
relevant behaviors.  Opiates have been shown to cause immunosuppression in the 
periphery; however, no studies have addressed the effects of opiates on central 
immune responses.  The experiments described herein are the first to examine the 
effects of opiates on immune activation in the CNS. 
 
Brief overview of the immune system 
The immune system is divided into two major components: adaptive and 
innate.  The adaptive immune system includes T and B cell responses, and requires 
a lengthy response time to form specialized responses to microbial infections.  The 
innate immune system is more relevant to this dissertation and performs less 
specialized but more immediate responses to microbial infections.  This part of the 
immune system plays an important role by performing as the first line of host 
defense against microbial infection (Iwasaki & Medzhitov, 2010).  Within the innate
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immune system, there are many types of cells, and of these, macrophages will be 
most discussed here.  In addition to phagocytizing (or consuming) foreign cells, 
macrophages are responsible for the release of protein messengers known as 
cytokines.   When host defense mechanisms are engaged (such as during a 
bacterial or viral attack), macrophages secrete proinflammatory cytokines, which aid 
the adaptive immune system and help to destroy the foreign invaders.  These 
proinflammatory responses are vital to an effective host defense. Proinflammatory 
cytokines released from resident macrophages and astrocytes, such as tumor 
necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and monocyte 
chemotactic protein-1(MCP-1), are integrally involved in assisting important 
inflammatory responses, including the production of nitric oxide via inducible nitric 
oxide synthase (iNOS) (Hart, 1988b; Cannon, 2000; Thompson, Karpus, & Van 
Eldik, 2008).  Throughout this document, the proinflammatory cytokines listed above 
and other proinflammatory non-cytokines will be collectively referred to as 
proinflammatory mediators.  The proinflammatory mediators function as an essential 
first line response to microbial infection in addition to recruiting other immune cells to 
the site of infection (Wang et al 2008).   
 
Proinflammatory responses in the central nervous system 
In the CNS, cells are generally either neurons or glial cells.  Often in 
neurobiology, the focus is almost exclusively on neurons.  However, glial cells 
outnumber neurons 10:1 in the brain, and these cells are becoming increasingly 
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popular topics of study due to new findings that glial cells have vital roles in 
regulation of neuronal communication.  Within the glial cells, microglia are often 
targets for studies examining modulation of neuron health and neural 
communication.  The responses of microglia have become an important area of 
study due to their important effects on neurons, so in order to understand these 
cells, some understanding of the functioning of the immune system is necessary. 
As a subset of macrophages, microglia in the brain are also responsible a 
number of roles, including sensing pathological events in the CNS, supporting 
neurons, and releasing proinflammatory mediators (Kreutzberg, 1996; Perry, Hume, 
& Gordon, 1985).  In addition to serving the immune functions above, the 
proinflammatory mediators perform important signaling functions to affect neuronal 
communications.  While inflammatory responses by the innate immune system are 
well characterized in the periphery, less is known about the importance of these 
responses within the CNS.  It has only become apparent in the past 15-20 years that 
these immune responses exist in the brain at all; prior to this time, the brain was 
believed to be “immune privileged” and not subject to the normal immune response 
due to the blood brain barrier.  In fact, it is now abundantly clear that 
proinflammatory cytokines are can be induced in the brain during immune system 
activation, particularly in the hypothalamus and hippocampus (Laye, Parnet, Goujon, 
& Dantzer, 1994; O'Connor et al., 2003).      
A common method for studying the immune response in vivo is by using 
lipopolysaccharide (LPS), a Gram negative bacterial cell wall fragment which is 
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recognized by innate receptors, resulting in an immune response similar to that seen 
in an active infection.  This allows for experiments examining the immune response 
without the complicating factor of a live infection.  In laboratory settings, stimulation 
by LPS produces a proinflammatory effect with elevated TNF-α, IL-1β, and IL-6 in 
the brain, particularly in the hypothalamus and hippocampus (Chen et al., 2008; 
Richwine, Sparkman, Dilger, Buchanan, & Johnson, 2009).  Many of the 
proinflammatory mediators induced by LPS, including IL-1β, IL-6, TNF-α, iNOS, 
MCP-1, are all regulated by a common transcription factor, nuclear factor kappa B 
(NFκB) (O'Neill & Kaltschmidt, 1997).  Activated NFκB is responsible for the 
proinflammatory effects of LPS in microglia (Nakajima, Matsushita, Tohyama, 
Kohsaka, & Kurihara, 2006).  It is possible that this is one mechanism that can be 
manipulated to alter proinflammatory mediator production. 
 
Sickness behaviors 
Communication between the immune system and the central nervous system 
by cytokines is now known to be integral to a constellation of behaviors, collectively 
known as sickness behaviors.  Sickness behaviors, rather than being a side effect of 
immune activation as previously thought, are believed to be a directed and 
organized behavioral response to aid the organism in recovering from infection 
(Hart, 1988a; Maier & Watkins, 1998b).  The brain regions where the most cytokine 
activity is seen include the hippocampus and hypothalamus, and these regions are 
the ones most associated with sickness behaviors.  Cytokines were first proposed to 
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have an active role in the brain by Dantzer and Kelley (Dantzer & Kelley, 1989).  
Since that time, a number of cytokines have been definitively linked to sickness 
behaviors, particularly fever production.  These cytokines include TNF-α, IL-1β, and 
IL-6 (Conti, Tabarean, Andrei, & Bartfai, 2004; Kluger, Kozak, Leon, Soszynski, & 
Conn, 1995).    
Sickness behaviors consist of a number of beneficial immune responses, 
including production of fever, a reduction in social activities and general activity, 
fatigue or sleepiness, and anorexia (Dantzer & Kelley, 2007; Hopkins, 2007; Campisi 
et al., 2003; Conti et al., 2004; Hori et al., 1991; Conti et al., 2004; Kluger et al., 
1995; Blatteis, Li, Li, Feleder, & Perlik, 2005; Jansky et al., 1995; Konsman, Parnet, 
& Dantzer, 2002; Dantzer et al., 2007).  These behaviors are exhibited during 
infection and have evolved as adaptive responses to increase survival during 
bacterial or viral attacks (Kluger, Kozak, Conn, Leon, & Soszynski, 1996; Kluger, 
Kozak, Conn, Leon, & Soszynski, 1998).  Sickness behaviors are now believed to 
represent a shift in motivation state to reorganize the organism’s resources towards 
fending off infection (Dantzer et al., 2007).  These behaviors are adaptive in a 
number of ways, most centering on the production of fever. 
 Fever is a complex but essential aspect of sickness behavior and a vital 
component of the immune system response to infection.  The idea that fever is an 
adaptive immune process was believed as long ago as ancient Greece, and this 
idea has reemerged with substantial scientific evidence behind it (Mackowiak, 1998).  
Fever production is an evolutionarily conserved adaptation that can be seen in 
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animals ranging from humans to mollusks, which indicates the significance this 
behavior (Kluger, 1978).  Fever has a number of advantageous responses, including 
causing a more efficient functioning of leukocytes and macrophages (Sebag, Reed, 
& Williams, Jr., 1977; Manzella & Roberts, Jr., 1979).  These changes translate to 
effects on disease outcome, as recent studies have shown that the suppression of a 
normal fever response during infection increases morbidity for many diseases, and 
allowing fever to be produced is beneficial in most cases (Kluger et al., 1998; Kluger 
et al., 1996).   
 The production of fever has been studied extensively for many decades, 
which allows for a solid foundation of knowledge of mechanisms.  Although there is 
some debate about alternative pathways, the classical “fever pathway” is initiated by 
the production of endogenous pyrogens, which are typically proinflammatory 
cytokines.  In particular, IL-1β and IL-6 are associated with the playing a pivotal role 
in the onset of fever, although TNF-α and other proinflammatory mediators have also 
been shown to have pyrogenic activity (Kluger et al., 1995; Dinarello, 2004; Harden, 
du, I, Poole, & Laburn, 2006; Harden, du, I, Poole, & Laburn, 2008; Kozak et al., 
1995; Kozak et al., 1998; Stefferl, Hopkins, Rothwell, & Luheshi, 1996).  These 
pyrogenic factors then trigger production of prostaglandin E2 (PGE2 ) in the 
hypothalamus (Nilsberth, Hamzic, Norell, & Blomqvist, 2009b; Nilsberth et al., 
2009a; Griffin, 1999).  The synthesis of PGE2 via the inducible enzyme 
cyclooxygenase-2 (COX-2) is traditionally viewed as the final and obligatory step in 
the classical fever pathway, directly affecting thermosensitive neurons in the 
hypothalamus which then regulate physiological responses to produce an increase 
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in body temperature (Nilsberth et al., 2009b).  See Figure 1 (page 11) for a 
schematic of the traditional fever pathway. 
 While fever is associated with the hypothalamus, behavioral depression as 
noted by reduction of activity is associated with the hippocampus, a more recent 
development in this field (Konsman et al., 2008; Harden et al., 2006; Harden et al., 
2008; Konsman et al., 2002; Linthorst, Flachskamm, Holsboer, & Reul, 1994).  A 
reduction of activity is not immediately apparent as evolutionarily adaptive until one 
considers the costliness in terms of energy of fever.  While fever is clearly adaptive 
for mounting an effective immune attack in order to clear microbes from the body, it 
is metabolically expensive, and a reduction in general activity helps to compensate 
for this cost and allows the redirection of energies towards producing fever- this is 
the change in motivational state mentioned above.  High levels of proinflammatory 
mediators such as TNF-α and IL-6 in the hippocampus have been implicated in 
increased release of hippocampal serotonin, which then results in behavioral 
depression (Pauli, Linthorst, & Reul, 1998; Anisman, Gibb, & Hayley, 2008; Linthorst 
& Reul, 1998).  For the purposes of this dissertation, behavioral depression will refer 
to the reduction of overall activity, although some researchers include decreased 
sociability and reduction of feeding/drinking behaviors in this classification. 
 
Opiate-induced immunosuppression  
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Opiates such as morphine and heroin have been linked to producing 
immunosuppression through a number of mechanisms, as well as having a variety of 
effects on body temperature.  The consequence of this is seen in opiate abusers 
who suffer from an increased rate of a variety of bacterial infections.  Opiates are 
known to produce immunosuppression in the peripheral system (including spleen 
and blood) through central nervous system pathways, particularly by suppressing 
activation of the innate immune system and proinflammatory cytokines such as IL-1β 
and TNF-α (Wang, Barke, Ma, Charboneau, & Roy, 2008; Chuang et al., 2005; 
Mellon & Bayer, 1998).  However, essentially nothing is known regarding the effect 
of opiates on immune responses that occur within the central nervous system.  One 
study indicated that morphine decreases fever response, which was correlated with 
decreased serum proinflammatory mediators (Mayfield, Kozak, Rudolph, & Kluger, 
1998).  Given the accepted importance of CNS proinflammatory mediators in 
producing fever, the impairment of fever by opiates as found by Mayfield et al. 
suggests a suppression of proinflammatory mediators in the CNS.  However, no 
published reports have directly examined the effects of morphine or heroin on 
proinflammatory mediator levels in the brain.  Due to the established peripheral 
immunosuppressive effects of these opiates, it is likely that opiates also produce 
immunosuppression in the CNS.  Impairments of proinflammatory mediators in the 
CNS, given the role of these molecules in sickness behavior, may also translate to 
alterations of adaptive sickness behaviors normally mediated by proinflammatory 
mediators in the CNS.   
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Interaction of opiates and body temperature 
In addition to inhibiting LPS-induced fever, morphine and other μ opioid 
receptor agonists have independent effects on body temperature.  Low to moderate 
doses of morphine induce hyperthermia through actions on the μ opioid receptors, 
although high doses can produce hypothermia through actions on the κ or δ opioid 
receptors (Baker & Meert, 2002; Geller, Hawk, Tallarida, & Adler, 1982).  However, 
this pathway may be distinct from that of the classical fever pathway due to 
conflicting evidence of the necessity of PGE2  as well as a more rapid onset of 
effects (1-2 hours) that subsides much more quickly compared to traditional fever 
(Wallenstein, 1983; Prakash & Dey, 1981).  The end result of hyperthermia due to 
MOR activation is, like fever, mediated by thermosensitive neurons in the 
hypothalamus, but the pathway leading to this outcome is not fully understood 
(Yakimova, Sann, & Pierau, 1996).  The interaction between exogenous opiates 
such as heroin and morphine through μ receptors in thermal regulation by both in 
impairing fever and inducing hyperthermia has yet to be addressed 
comprehensively.  Interestingly, morphine treatment has also been shown to 
downregulate proopiomelanocortin (POMC), the precursor protein to the 
endogenous opioid β-endorphin, which also binds to the μ receptor (Mocchetti, 
Ritter, & Costa, 1989).  Heroin addicts also have impaired β-endorphin responses in 
thermal regulation, indicating that endogenous opioids may also play a role in 
thermoregulation and exogenous opiates may alter these responses (Vescovi & 
Coiro, 1993; Vescovi et al., 1989).  The seemingly contradictory results -- opiate-
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induced hyperthermia yet opiates suppress LPS-induced fever – have yet to be 
comprehensively addressed.   
 
Overview of experiments 
The experiments described in the following chapters evaluated the effects of 
opiates on body temperature and activity levels as well as how these behaviors 
correlated with stimulation of proinflammatory mediators.  These experiments take 
on a number of problems that have not been previously addressed in the literature.  
The overarching goal of these aims is to evaluate the effects of heroin on behavioral 
depression and fever as immunologically relevant behaviors and proinflammatory 
mediators in associated brain regions.  Chapter 2 evaluated the effects of heroin on 
core body temperature and proinflammatory mediators during heroin-induced 
changes in the brain, specifically the hypothalamus.  Chapter 3 furthered the 
investigations by examining fever production by LPS and expression of 
proinflammatory mediators in the hypothalamus with and without concurrent heroin 
administration.  Chapter 4 measured proinflammatory mediator expression in the 
hippocampus induced by systemic LPS treatment and determined if co-
administration of heroin can inhibit the expression of proinflammatory mediators in 
the hippocampus, as well as evaluated the behavioral depression seen under these 
conditions as measured by general activity.   
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Figure 1.   Schematic of traditional fever pathway 
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Chapter 2 
Heroin-induced hyperthermia is not regulated by proinflammatory mediators 
associated with the traditional fever pathway. 
 
Introduction 
 Opiates have complex effects on the regulation of body temperature.  
Morphine has a dose-dependent effect on body temperature, with high doses 
causing hypothermia and low doses causing hyperthermia (Dafters & Taggart, 1992; 
Geller, Hawk, Keinath, Tallarida, & Adler, 1983).  It has become clear that the 
hyperthermic effects of morphine are mediated through the μ receptor, as these are 
prevented by μ antagonists as well as antisense oligonucleotides designed to block 
the μ receptor, while the hypothermic effects are mediated by the κ receptors 
(Thornhill, Hirst, & Gowdey, 1978; Chen, Geller, DeRiel, Liu-Chen, & Adler, 1996; 
Bhargava, Rahmani, Villar, & Larsen, 1993; Handler, Geller, & Adler, 1992).  Self 
administered heroin also produces a hyperthermia that can be reversed with 
naloxone and is not associated with activity increases, indicating that the rise in body 
temperature is centrally mediated (Kiyatkin & Wise, 2002).  These thermic effects 
occur very quickly after opiate treatment, even when given systemically, usually 
between 30 minutes and 3 hours.  These effects are more rapid than the typical
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fever in response to an immune challenge, but the involvement of proinflammatory 
cytokines is unknown.   As discussed before and elsewhere in this dissertation, fever 
involves an increase in proinflammatory cytokines and PGE2 to affect 
thermosensitive neurons in the hypothalamus.  Evidence indicates that morphine 
and heroin can produce a brief burst of proinflammatory cytokines within the first 
hour of treatment, followed by a period of depressed cytokine production (Pacifici, 
Di, Bacosi, Pichini, & Zuccaro, 2000).  However, it is unknown if this brief increase in 
proinflammatory cytokines occurs in the brain or if that phenomenon relates to the 
thermic effects of opiates. 
 The effects of opiates on body temperature are even more complex when an 
immune challenge is present.  Given the abundant evidence that μ opiates typically 
suppress proinflammatory mediators in the periphery, it perhaps should not be 
surprising that morphine suppresses fever production by LPS, which was correlated 
with decreased plasma levels of IL-6 and TNF-α (Mayfield, Kozak, Rudolph, & 
Kluger, 1998).  The suppression of fever suggests that opiates have suppressive 
effects on proinflammatory cytokines in the brain, specifically in the hypothalamus; 
however, no studies to date have examined the relationship between opiates, 
proinflammatory cytokines in the hypothalamus, and fever.  If heroin temporarily 
increases proinflammatory mediators as the study by Pacifici suggests, the short-
term increase in proinlammatory mediators could affect the ability of the 
hypothalamus to respond appropriately to an immune challenge.  The following 
studies were performed to determine if the hyperthermic effect of heroin is mediated 
by proinflammatory cytokines and PGE2, similar to fever.   
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Overview of experimental procedures.   
 In order to examine the hyperthermic responses induced by heroin, a number 
of experiments were performed.   
 Experiment 1a.  Based on pilot studies, we sought to examine a low (1mg/kg) 
and a high (10mg/kg) dose of heroin in reference to effects on body temperature.  
Rats (n=24) were given 0mg/kg, 1mg/kg, or 10mg/kg of heroin while body 
temperatures were measured.   
 Experiment 1b.  In this experiment, we aimed to determine if pretreatment 
with indomethacin (10mg/kg), an inhibitor of prostaglandin synthesis, would prevent 
the hyperthermic response of heroin (1mg/kg).  Indomethacin was dissolved in 
DMSO and rats (n=8) were administered either vehicle or indomethacin.  One hour 
later, all rats were given 1mg/kg of heroin.   
 Experiment 1c.  In this experiment, rats (n=24) were given 1mg/kg of heroin 
or saline and 1mg/kg of LPS or saline.  LPS was included in this study to determine 
if the cytokine response was altered in the presence of an immune challenge during 
the hyperthermic response by heroin.  Rats were then sacrificed at 90 minutes post-
treatment, which previous studies have shown is during the peak hyperthermic 
response to heroin.  Brain tissue was dissected and processed immediately for 
mRNA analysis of proinflammatory mediators via RT-PCR.  Target molecules 
include the proinflammatory cytokines TNF-α, IL-1β, IL-6, and MCP-1, as well as 
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iNOS, IκBα as a measure of NFκB activation, and COX-2 as a measure of PGE2 
synthesis activity.  IκBα is a protein that must be removed and degraded to allow for 
the translocation of NFκB into the nucleus (for review of NFκB, see O'Neill & 
Kaltschmidt 1997).  The production of new IκBα is indicative of degradation of IκBα 
that occurs during NFκB activation, and levels of IκBα mRNA are used as a measure 
of NFκB activation (Zhao et al., 2007).  
  
Materials and Methods 
Animals 
  All methods were approved by University of North Carolina at Chapel Hill’s 
Institutional Animal Care and Use Committee (IACUC) and are in accordance with 
National Institutes of Health (NIH) guidelines as an Association for Assessment and 
Accreditation of Laboratory Animal Care (AAALAC)-accredited facility.  All animals 
were individually housed on a 12:12 light:dark cycle in temperature-controlled 
Division of Laboratory Animal Medicine (DLAM)-approved facility with lights on at 
7:00AM.  All experimental manipulations took place during the dark portion of the 
light cycle.  Rats were allowed at least one week to habituate to the new 
environment prior to any experimental manipulations.  Food and water were 
available ad libitum.  For all experiments, Lewis male rats were purchased at 
approximately 2-3 months in age (Charles River Laboratories, Raleigh, NC).  There 
were a total of 48 rats used for these experiments. 
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Surgical procedures 
  Surgeries were performed to implant biotelemetry devices within the 
abdominal cavities of the rats. The rats were anesthetized by administering a 0.3 ml 
intraperitoneal injection of ketamine (90 mg/ml) and xylazine (10 mg/ml). A small 
incision was made down the midline of the abdomen through the dermis, followed by 
an incision to the linea alba. The E-Mitter (Mini-Mitter, Sunriver, OR) was placed in 
the abdominal cavity and sutured to the abdominal musculature. The abdominal 
musculature and the dermis were sutured separately. The rats were allowed at least 
one week to recover before further experimental procedures were conducted.  
 Home cages were placed directly on top of the biotelemetry receivers, which 
then transmitted data recordings of core body temperature and activity measures to 
VitalView software on a computer located within the room (Mini-Mitter, Sunriver, 
OR).  Body temperatures were recorded at one minute intervals for the duration of 
the experiments. 
 
Drug administration 
  All injections of heroin, indomethacin, LPS, or saline were given 
subcutaneously on the abdomen.  LPS was E. coli derived and purchased from 
Sigma-Aldrich (St. Louis, MO). Indomethacin was also purchased from Sigma-
Aldrich.   
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Dissection procedures 
  Immediately following cervical dislocation, brains were extracted rapidly and 
target regions (hypothalamus, hippocampus, cortex, striatum) were dissected 
immediately.  Target tissues were dissected using Paxinos and Watson as a guide 
(Paxinos & Watson, 2005), extracting the entire hypothalamus, entire hippocampus, 
cortical tissue immediately dorsal to the hippocampus, and striatum tissue 
immediately ventral to the hippocampus.  Tissues were stored in RNAlater (Ambion, 
Austin, TX) at -80°C until processed for RNA extraction.   
 
Real time reverse transcription polymerase chain reaction (RT-PCR) 
          Total RNA was extracted from each of these brain tissues using Tri-Reagent 
(Molecular Research Center, Inc., Cincinnati, OH), following modified methods 
described by Chomczynski & Sacchi (1987).  The RNA was quantitated 
spectrophotometrically (GeneQuant II, Pharmacia-Biotech, Piscataway, NJ).  
Reverse transcription was performed using Oligo(dt)18 primer and Moloney Murine 
Leukemia Virus-Reverse transcriptase following the protocol of the Advantage™ RT-
for-PCR Kit from Clontech (Palo Alto, CA).  PCR amplications were performed using 
the LightCycler TaqMan Master kit (Roche Diagnostics, Indianapolis, IN), in which 
reaction components were prepared in a master mix solution.  Each reaction 
consisted of 17µl of master mix with 3µl of sample placed in glass capillary tubes 
designed for the LightCycler system.  Capillaries were then placed in the LightCycler 
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instrument (Roche Diagnostics).   The samples and master mix were pre-incubated 
for 10 minutes at 95 degrees Celsius and amplified for 45 cycles of 10 seconds at 95 
degrees followed by 30 seconds at 60 degrees using specifically designed PCR 
primer sets for each target molecule (TNF-α, IL-1β, iNOS, MCP-1, IL-6, IkBα and 
COX-2) that were synthesized by the Nucleic Acids Core Facility (Lineberger Cancer 
Center, University of North Carolina at Chapel Hill) (see Table 1 for sequences).  
Fluorescence level was determined at the end of the amplification phase for each 
cycle of PCR. Each run included negatives and an internal standard curve.   
 
Data and Statistical Analysis   
 Body temperature data analysis.  Body temperature data was analyzed based 
upon samples made at every half hour point that was averaged over three data 
points (e.g., for measurement of half an hour after treatment, data from the 29, 30, 
and 31 minutes post-treatment were analyzed and represented the 30 minute data 
point for each rat).  Body temperatures were followed for 120 minutes after heroin 
treatment.   
 Proinflammatory mediator mRNA data analysis.  To ensure comparable 
quality of RNA among samples, the housekeeping gene calnexin (CANX) was 
assessed and target molecule data were expressed as a ratio to amount of CANX 
measured.   
 Statistics.  All statistics were performed using SPSS v17.0.  For Experiment 
1a, repeated measures ANOVA was used to determine if there was a time * heroin 
interaction.  For Experiment 1b, a repeated measures ANOVA was used to 
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determine if there was a time * indomethacin interaction.  If interactions were found, 
Tukey posthoc tests were performed.  For mRNA data from Experiment 1c, ANOVAs 
were performed examining the main effects and interactions for LPS and heroin for 
all proinflammatory mediators, and Tukey posthoc tests were also performed when 
significant effects were found.  Significance was set at p=0.05.   
 
Results 
Experiment 1a 
  Pilot studies and published experiments suggested that 1mg/kg and 10mg/kg 
of heroin have very different effects on body temperatures.  Experiment 1a furthered 
that exploration of body temperature effects by heroin and investigated high 
(10mg/kg) and low (1mg/kg) doses.  The repeated measures ANOVA revealed a 
significant time * heroin interaction [F(1,64)=3.278, p≤0.01].  Posthoc tests indicated 
the 1mg/kg heroin treated group was significantly elevated compared to the saline 
treated group treated group post-treatment at 30 minutes (p≤0.01), 60 minutes 
(p≤0.05), and 90 minutes (p≤0.05).  The 10mg/kg treated group did not differ from 
either group at any time point as a result of a large amount of variability, which was 
also seen in the pilot studies conducted in our laboratory as a result of this large 
dose.  From these results, we conclude that 1mg/kg of heroin reliably induces a 
hyperthermic effect, and thus can be used for future studies evaluating the effects of 
heroin (Figure 2.1a). 
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Experiment 1b 
 This experiment evaluated whether pre-treatment with indomethacin, a 
prostaglandin synthesis inhibitor, would prevent the hyperthermic effect of heroin.  A 
repeated measures ANOVA based on the 2 hours of data post-treatment with heroin 
(and three hours post-indomethacin pretreatment) indicated that there was no 
difference between indomethacin pre-treated rats and those treated with vehicle 
[F(4,24)=0.329, p=0.856].  The lack of difference between the two groups indicates 
that indomethacin did not affect the hyperthermic response by heroin, and 
prostaglandins are likely not necessary for production of this response.  There was, 
however, a significant effect of time [F(4,24)=12.424, p≤0.001], and paired sample t-
tests confirmed that body temperature was elevated (compared to baseline) at 60 
minutes [t(7)=5.960, p≤0.001], 90 minutes [t(7)=7.432, p≤0.001], and 120 minutes 
[t(7)=6.499, p≤0.001] post-treatment with heroin, thus confirming that heroin in both 
groups increased body temperature at these time points.  There were no differences 
in body temperatures prior to these time points, indicating that neither indomethacin 
nor the vehicle had any immediate effects on body temperature (Figure 2.1b). 
 
Experiment 1c: RT-PCR   
 Hypothalamus.  The primary purpose of this experiment was to examine 
hypothalamic proinflammatory mediator mRNA during the hyperthermic peak 
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produced by heroin; however, we also decided to examine other brain regions for 
comparison.  In the hypothalamus, there was a main effect of LPS in TNF-α 
[F(1,22)=10.803, p≤0.01], IL-1β [F(1,22)=18.410, p≤0.001], MCP-1 [F(1,22)=7.818, 
p≤0.01], IL-6 [F(1,22)=7.678, p≤0.01], and Iκβα [F(1,23)=8.955, p≤0.01] mRNA.  In 
addition to the main effect of LPS, IL-6 mRNA also demonstrated a main effect of 
heroin [F(1,22)=7.761, p≤0.01] and an interaction of LPS * Heroin [F(1,22)=4.255, 
p≤0.05].  Posthoc tests revealed that LPS/saline treatment increased IL-1β mRNA 
compared to saline/saline and heroin/saline treated groups, but there were no 
differences between the saline/LPS and heroin/LPS groups.  IκBα mRNA levels 
were significantly different only between the heroin/saline treated groups and the 
saline/LPS treated groups, while IL-6 mRNA levels indicated that the saline/LPS 
treated group was significantly elevated compared to all three other groups.  (Figure 
2.2) 
 Hippocampus.  A 2 (LPS) by 2 (heroin) ANOVA for each proinflammatory 
mediator measured was performed.  There were no significant results from the 
hippocampus.  (Figure 2.3) 
 Cortex.  In the cortex, there were no significant effects of LPS, heroin, or 
interactions of the two in the measures of any of the proinflammatory mediators 
measured, with the exception of IL-6, which had a significant main effect of LPS 
[F(1,20)=6.256, p≤0.05].  Posthoc tests revealed only a difference between the 
heroin/saline treated group and the LPS/saline treated group (p≤0.05), but 
importantly, there were no differences compared to the saline/saline treated group.  
(Figure 2.4) 
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 Striatum.  A 2 (LPS) by 2 (heroin) ANOVA for each proinflammatory mediator 
measured was performed.  There was an interactive effect of LPS * heroin in the 
measure of TNF-α mRNA [F(1,19)=6.621, p≤0.05]; posthoc tests revealed only a 
difference between the heroin/LPS treated group and saline/LPS treated group, 
indicating that the heroin/LPS treated group had significantly higher levels of TNF-α 
mRNA compared to the saline/LPS treated group.  IL-1β mRNA analysis 
demonstrated a significant main effect of LPS [F(1,19)=4.943, p≤0.05]; however, 
none of the posthoc tests were significant.  Likewise, MCP-1 mRNA showed a main 
effect of LPS [F(1,20)=4.342, p≤0.05], but no groups were revealed to be 
significantly different than the others.  These results indicate that LPS has a slight 
effect in elevating proinflammatory mediators, but it is not a robust effect, and it is 
not affected or is suppressed by heroin co-administration in the striatum.  (Figure 
2.5) 
 
Discussion 
Major findings 
 These experiments demonstrated clearly that 1mg/kg heroin induces a 
hyperthermic effect that is not reversed by PGE2 and does not rely on the same 
mechanisms as traditional fever; that is, the hyperthermic effect of heroin does not 
induce proinflammatory mediators or depend on synthesis of PGE2 in the 
hypothalalmus during increased body temperature to produce this effect.   
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Proinflammatory mediator mRNA during peak of heroin-induced hyperthermia 
 The first two experiments in this chapter indicated that heroin induces a 
hyperthermic effect which peaks at 90 minutes post-treatment.  We investigated 
whether opiates such as heroin cause this fast hyperthermic response through a 
relatively quick increase in proinflammatory cytokines.  The results indicate that 
heroin treated rats, with or without LPS, did not show increased proinflammatory 
mediator mRNA, and in fact, the only group that showed any increased responses 
was the LPS/saline treated group.  These results clearly indicate that heroin does 
not increase proinflammatory cytokine production during the peak of hyperthermia, 
and this phenomenon is distinct from fever production due to an immune challenge 
(such as LPS, as in these experiments).  We must consider, then, other possibilities 
for the thermic response of opiates. 
 
Direct effects of opiates on hypothalamic neurons 
 Within the hypothalamus, there are three distinct types of neurons that are 
relevant to fever production:  warm sensitive neurons, temperature insensitive 
neurons, and cold sensitive neurons.  Warm sensitive neurons comprise about 30% 
of the neurons in this region, and when activated, induce behaviors that cool the 
body (i.e., these neurons sense warmth and respond accordingly to sustain 
homeostasis).  Cold sensitive neurons only make up about 5% of the POA, and the 
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effects of these neurons are the opposite of the warm sensitive neurons, although 
their small number renders them less studied than the others (Griffin, 1999).  
Alterations in these neurons produce a change in temperature set point, which can 
result in hyperthermia (in this case, fever) or hypothermia.  Inhibition of warm 
sensitive neurons results in a body temperature set point change upwards, or 
hyperthermia; indeed, IL-1β and presumably other proinflammatory cytokines 
decrease activity of warm sensitive neurons in the hypothalamus in a PGE2-
dependent manner (Nakashima, Hori, Mori, Kuriyama, & Mizuno, 1989; Griffin, 1999; 
Boulant, 1998).   
 Interestingly, morphine has been reported to have direct but conflicting effects 
on the activity of warm sensitive neurons in the POA, with some studies reporting a 
decrease in activation while others reported an increase in neuron firing (Baldino, 
Jr., Beckman, & Adler, 1980; Yakimova et al., 1996).  In the Baldino et al 
experiment, morphine caused an increased firing of warm sensitive neurons, which 
would presumably lower body temperature in a whole organism, and this effect was 
antagonized by naloxone.  In the Yakimova et al experiment, the investigators 
demonstrated that morphine decreased sensitivity of warm sensitive neurons, which 
can be extrapolated to mean that morphine would cause an increase in body 
temperature.  This effect was reversed by the selective μ antagonist CTOP.  The 
difference in the studies is minute, but it is possible that naloxone, while selective for 
μ, also had an antagonistic action at other opioid receptors, namely κ receptors.  
Since κ agonists increase excitation in warm sensitive neurons from the POAH, an 
antagonism of these receptors would account for the results seen by Baldino et al 
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(Yakimova, Sann, & Pierau, 1998).  An excitation of κ receptors by morphine has 
been shown to occur and moreover, to induce a hypothermic effect.  Therefore, it 
seems more likely that activation of μ receptors can induce a hyperthermic effect by 
directly acting on hypothalamic thermosensitive neurons. 
Our results indicating that heroin does not increase proinflammatory cytokines 
in the hypothalamus during the hyperthermic peak indicates that cytokine activity is 
not likely to play a role in in the thermic effects of heroin, and it is more likely that 
opioid receptors themselves are responsible for these effects.   
 
Conclusion 
 It can be concluded that the hyperthermic effect induced by heroin does not 
rely on the traditional fever pathway to produce the rise in body temperature, as 
evidenced by the lack of increased proinflammatory mediators in the hypothalamus 
or alteration by a PGE2 synthesis inhibitor.  However, the question of how heroin 
affects fever, and the potential for disruption in the production of proinflammatory 
mediators as suggested in the results of IL-6 mRNA in this chapter has yet to be 
investigated.  The following studies examine potential mechanisms through which 
heroin might disrupt fever production. 
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Table 1.   Primer information used for RT-PCR. 
Gene 5' Primer 
5' 
Size 3' Primer 
3' 
Size 
Amp 
Size 
CANX agcaagcctaaagcagagga 20 gaccatatttgcaggggaag 20 133 
TNFα gggcctccagaactccag 18 gagcccatttgggaacttct 20 139 
IL-1β agcttcaggaaggcagtgtc 20 tcccacgagtcacagagga 19 149 
iNOS tgaggattacttcttccagctca 23 tgggtgtcagagtcttgtgc 20 130 
MCP-1 cagaaaccagccaactctca 20 gtggggcattaactgcatct 20 144 
IL-6 cctggagtttgtgaagaacaact 23 ggaagttggggtaggaagga 20 142 
IκBα ccaactacaacggccaca 18 ctgtccggccattacagg 18 123 
COX-2 gaccaggagtacactttcaaacag 24 attccttcccccagcaac 18 123 
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 Figure 2.1   (a) Heroin dose-dependently affects core body temperature.  Body 
temperature was measured via 1 minute samples taken over 3 minutes and 
averaged per rat at every half hour interval.  Body temperature measurements 
indicate that a dose of 1mg/kg (s.c.) of heroin increased body temperature compared 
to treatment with saline, while a dose of 10mg/kg (s.c.) of heroin did not produce any 
significant effects due to variability.  (b) Heroin (1mg/kg, s.c.) produced an increase 
in core body temperature compared to baseline core body temperature.  Heroin-
induced hyperthermia was not affected by indomethacin treatment (10mg/kg, s.c.). 
Data is represented as means by treatment group with standard error of means 
(SEM).   * denotes significance of at least p≤0.05. 
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Figure 2.2   Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS (1mg/kg) 
or saline.  Sacrifice occurred 90 minutes after treatment.  Data is represented as 
means and SEM of mRNA ratios compared to housekeeping gene CANX as 
measured through RT-PCR.  * denotes significance of at least p≤0.05.  The following 
graphs represent the mRNA levels measured in the hypothalamus.  (a)  TNF-α (b) 
IL-1β (c) iNOS (d) IL-6 (e) MCP-1. 
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 Figure 2.3  Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS (1mg/kg) 
or saline.  Sacrifice occurred 90 minutes after treatment.  Data is represented as 
means and SEM of mRNA ratios compared to housekeeping gene CANX as 
measured through RT-PCR.  * denotes significance of at least p≤0.05.  The following 
graph represents the mRNA levels of (a) IκBα and (b) COX-2 measured in the 
hypothalamus and (c) IκBα and (d) COX-2 in the hippocampus.   
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Figure 2.4   Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS (1mg/kg) 
or saline.  Sacrifice occurred 90 minutes after treatment.  Data is represented as 
means and SEM of mRNA ratios compared to housekeeping gene CANX as 
measured through RT-PCR.  * denotes significance of at least p≤0.05.  The following 
graphs represent the mRNA levels measured in the cortex.  (a)  TNF-α (b) IL-1β (c) 
iNOS (d) IL-6 (e) MCP-1 
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Figure 2.5  Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS (1mg/kg) 
or saline.  Sacrifice occurred 90 minutes after treatment.  Data is represented as 
means and SEM of mRNA ratios compared to housekeeping gene CANX as 
measured through RT-PCR.  * denotes significance of at least p≤0.05.  The following 
graphs represent the mRNA levels measured in the striatum.  (a)  TNF-α (b) IL-1β 
(c) iNOS (d) IL-6 (e) MCP-1  
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Chapter 3 
Heroin produces suppressive effects on proinflammatory mediators in the 
hypothalamus and subsequent febrile response. 
 
Introduction 
 In addition to the body temperature effects of opiates alone, it has also been 
reported that opiates such as morphine can inhibit fever production to LPS.  Fever 
production is regulated by the hypothalamus and has been studied extensively.  
Although there are alternate pathways proposed that likely exist, a traditional or 
classical fever pathway has been well-defined for many years.  Fever (also referred 
to as the febrile response) is discrete from general hyperthermia.   The fever 
response follows a distinct pathway initiated by a complex series of events beginning 
with a perceived immune challenge that typically requires several hours to initiate 
due to the necessary biological mechanisms that must be performed.  Hyperthermia, 
on the other hand, can be caused by any number of mechanisms, and is considered 
to be a more general term- fever is a type of hyperthermia, but not all hyperthermic 
responses are fevers.  The previous studies from Chapter 2 clearly indicate that 
heroin induces one of these such non-fever hyperthermias.  
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 As mentioned before, fever is a metabolically costly response that clearly 
must serve some evolutionarily adaptive function.  Indeed, a fever response to 
infection is conserved throughout the evolutionary tree of most animals, including 
mammals, reptiles, birds, and even mollusks (Kluger, 1978).  While the usefulness of 
fever can be dependent upon the type and duration of infection, one mechanism 
through which fever is beneficial is that increased body temperature serves to aid 
leukocytes in killing bacteria (Sebag et al., 1977).  Blockade of fever has unfavorable 
effects on clearance of bacteria and detrimentally affects mortality rates (Bernheim & 
Kluger, 1976; Kluger, Ringler, & Anver, 1975).   
 Proinflammatory cytokines are key initiators of the fever response.  IL-1β, 
TNF-α, and IL-6 are the most studied of the proinflammatory cytokines in relation to 
fever (Kluger et al., 1995; Jansky et al., 1995).  Administration of these cytokines 
into the hypothalamus, specifically the preoptic anterior region (POA), causes fever, 
and this can be reversed with specific antibodies or receptor antagonists for the 
cytokines (Conti et al., 2004; Fernandez-Alonso, Benamar, Sancibrian, Lopez-
Valpuesta, & Minano, 1996; Myers et al., 1994; Cartmell, Luheshi, & Rothwell, 
1999).  Although many studies have examined the effect of proinflammatory 
cytokines inducing fever, few have measured endogenous proinflammatory mediator 
production in the hypothalamus during fever production (Jansky et al., 1995). 
 IL-1β, TNF-α, and IL-6 are well established as inducers of fever, as is PGE2.  
PGE2 is typically viewed as the obligatory molecule in the traditional fever pathway.  
This is well supported throughout the literature- in mice unable to produce PGE2, IL-
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1β, IL-6 and TNF-α are all produced in the brain in response to LPS, fulfilling the 
initial stage of the fever pathway.  However, fever is never initiated in these mice, 
indicating that proinflammatory cytokine response is not dependent upon PGE2, but 
fever production is (Nilsberth et al., 2009b).  Inhibition of COX-2, the inducible 
enzyme responsible for synthesizing PGE2, via pharmacological means or genetic 
manipulation abolishes the fever response to LPS or IL-1β (Scammell, Griffin, 
Elmquist, & Saper, 1998; Li, Goorha, Ballou, & Blatteis, 2003; Li et al., 1999; Steiner 
et al., 2005).  The dependence of PGE2 action on COX-2 indicates that PGE2 must 
be induced and is not constitutively present.  Thus, the traditional fever pathway 
consists of the following events:  proinflammatory cytokines (IL-1β, TNF-α, and IL-6, 
usually) present in the hypothalamus, leading to the synthesis of PGE2, which then 
alters thermosensitive neurons in the POA, leading to behaviors that cause fever 
(shivering, warmth-seeking, blood vessel alterations).   
The μ receptor and fever 
 The μ receptor seems to play a variety of roles in the production of fever as 
well as the effects seen in Chapter 2.  In addition to the effects demonstrated by 
Mayfield et al of morphine impairing fever, antagonists to the μ opioid receptor 
injected peripherally and directly into the POAH prevent fever induced by IL-6, TNF-
α, and LPS (Benamar, Geller, & Adler, 2002; Benamar, Xin, Geller, & Adler, 2000; 
Blatteis, Xin, & Quan, 1991).  Mice that are deficient in the μ opioid receptor do not 
exhibit fever in response to LPS (Benamar et al., 2005; Benamar, Yondorf, Barreto, 
Geller, & Adler, 2007).  These studies indicate a potential role for the µ receptor in 
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fever production.  Numerous studies have indicated that β-endorphin can increase 
body temperature, and blockade of the μ receptors in studies such as those above 
would also block this effect (Rezvani, Gordon, & Heath, 1982; Tsai, Lin, Wang, & 
Huang, 2003; Tseng & Li, 1980; Vescovi et al., 1993; Martin & Bacino, 1979).  Like 
morphine and heroin, β-endorphin also causes hyperthermia at low doses but 
causes hypothermia in high doses (Rezvani et al., 1982).  In this case, activation of 
the μ receptors normally activated by β endorphin might explain the ability of heroin 
to induce hyperthermia.  Injection of β-endorphin in the POA of the hypothalamus 
increased body temperature in two peaks, but only the first rise was blocked by 
naloxone, while the other rise in body temperature was blocked by indomethacin 
(Martin et al., 1979).  It is possible that heroin is acting on the same receptors as β-
endorphin – μ opioid receptors – to produce a hyperthermic effect that is similar to 
the first rise seen with β-endorphin injection, while the second rise seen with β-
endorphin is connected to its potential role in fever production.  Drugs of abuse are 
well-known for hijacking pathways intended for adaptive processes such as 
motivation, so it is no surprise that heroin would also act in a similar manner as β 
endorphin, although it is not clear why heroin does not produce the second peak in 
body temperature like β-endorphin.  The role of β-endorphin in the production of 
fever is not yet well-defined, although as mentioned above, antagonizing the µ 
receptor does impair fever production (Martin et al., 1979; Benamar et al., 2007; 
Benamar et al., 2000).   The normal β-endorphin response has been shown to also 
be altered with heroin use, which may also affect the production of fever to LPS 
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(Vescovi, Coiro, Volpi, Giannini, & Passeri, 1992; Vescovi et al., 1989; Jezova, 
Vigas, Tatar, Jurcovicova, & Palat, 1985).        
 In the following experiments, we evaluate the effects of heroin on fever 
production in response to LPS.  Half of the rats were examined for mRNA analysis of 
proinflammatory mediators (TNF-α, IL-1β, iNOS, IL-6, MCP-1, IκBα, and COX-2) in 
the hypothalamus, while the other half of the rats were used to analyze protein levels 
of β-endorphin and the precursor molecule POMC.  The disruption of either of these 
arms would be may provide a mechanism for alterations of alter fever production by 
heroin. 
 
Materials and Methods 
Animals 
  Animals were housed under the same conditions and approvals as listed in 
Chapter 2.  There were a total of 48 rats used for these experiments. 
 
Surgical procedures   
 Surgical procedures were the same as listed above for implantations of 
biotelemetry devices.  As before, the rats were allowed at least one week to recover 
before further experimental procedures were conducted.   Home cages were placed 
and kept on top of the biotelemetry receivers.   
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Drug administration 
  All injections of heroin, LPS, or saline were given subcutaneously on the 
abdomen.  LPS was E. coli derived and purchased from Sigma-Aldrich (St. Louis, 
MO). 
  
Dissection procedures   
 Immediately following cervical dislocation at 8 hours post-treatment, brains 
were extracted rapidly dissected immediately.  Target tissues were dissected using 
Paxinos and Watson as a guide (Paxinos et al., 2005).  Half of the subjects were 
selected for mRNA analysis, while the other half were designated for protein 
analysis, spread evenly amongst all the groups.  Tissues for mRNA analysis were 
stored in RNAlater (Ambion, Austin, TX) at -80°C until processed for RNA extraction.  
Tissues for protein analysis were stored in an anti-proteinase buffer at -80°C.   
 
Real time reverse transcription polymerase chain reaction (RT-PCR) 
          The same procedures as reported previously in Chapter 2 were used to 
determine mRNA levels of proinflammatory mediators in the hypothalamus.  Total 
RNA was extracted from each of these brain tissues using Tri-Reagent (Molecular 
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Research Center, Inc., Cincinnati, OH), following modified methods (Chomczynski et 
al., 1987).  Quantification was performed as described before and cDNA was 
created for RT-PCR analysis.  The cDNA was then measured in individual runs of 
RT-PCR as previously described.  The target molecules for this analysis included 
the following: TNF-α, IL-1β, iNOS, IL-6, MCP-1, Ikβα, and COX-2.   
 
Protein extraction and β-endorphin Western blot 
 For the β-endorphin protein determination, protein was extracted from whole 
hypothalamus tissue immediately following sacrifice via cervical dislocation.  Protein 
was extracted using freeze/thaw lysis in sterile water containing antiproteinases.  
Total protein was determined spectrophotometrically (Model EL312 kinetic reader; 
Bio-Tek, Winooski, VT, USA) using Bio-Rad protein dye. A standard amount of 
protein (25µg) was loaded on a NuPage 3-8% Tris-acetate gel and 
electrophoretically separated and blotted to a presoaked polyvinylidene fluoride 
(PVDF) membrane (Invitrogen, Carlsbad, CA) .  The membrane was then blocked 
with 5% dry milk in a TBS-T buffer and reacted with a β-endorphin/Met-
enkephalin/β-LSH polyclonal goat antibody (Santa Cruz Biotechnology, Santa Cruz, 
CA) overnight.  The membrane was then washed thoroughly and incubated with cow 
anti-goat secondary antibody in 5% dry milk TBS-T.  Membranes were then washed 
and exposed to chromagen for 2-60 minutes and scanned for quantitative analysis.  
Analysis was performed using Image Pro® Plus program (Media Cybernetics, Silver 
Spring, MD), which measures density of the dyed protein.   
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Data and Statistical Analysis.   
 Body temperature data analysis.  Body temperature data was analyzed based 
upon samples made at every hour point that was averaged between five data points 
(e.g., for measurement of hour after treatment, data from the 58, 59, 60, 61, 62 
minutes post-treatment were analyzed and represented the 1 hour data point for that 
particular rat).  Body temperatures were followed until sacrifice of the rat via cervical 
dislocation at 8 hours after heroin treatment.   
 β-endorphin protein analysis.  Bands density was quantified and reported as 
means, which was the result of total band density divided by band area.   
 Proinflammatory mediator mRNA data analysis.  To ensure comparable 
quality of RNA among samples, the housekeeping gene calnexin (CANX) was 
assessed and target molecule data were expressed as a ratio to amount of CANX 
measured.   
 Statistics.  All statistics were performed using SPSS v17.0.  For body 
temperature data, repeated measures ANOVA was used to determine if there was a 
time * heroin interaction.  If interactions were found, Tukey posthoc tests were 
performed.  For mRNA and protein data, ANOVAs were performed examining the 
main effects and interactions for LPS and heroin for all proinflammatory mediators, 
and Tukey posthoc tests were also performed when significant effects were found.  
Significance was set at p≤0.05.  
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Results 
 
Body temperature  
 Body temperature data was analyzed using a mixed-design repeated 
measures ANOVA with LPS/saline and heroin/saline treatments as independent 
variables and time (using hourly timepoints) as a repeated measure.  Using this 
information, the ANOVA revealed a time * LPS * heroin interaction, [F(8,344)=5.765, 
p≤0.001].  Additionally, there was a between-subjects main effect of LPS 
[F(1,43)=11.671, p≤0.001].  Posthoc tests revealed a number of differences.   For 
Hour 1, the heroin/saline treated group was significantly elevated compared to the 
saline/saline treated group (p≤0.05), indicating that the heroin-induced hyperthermia 
occurred, which is consistent with the previous findings in Chapter 2.  At Hour 2, the 
saline/LPS treated group had a significantly lowered body temperature compared to 
the saline/saline (p≤0.001), heroin/saline (p≤0.001), and heroin/LPS (p≤0.001) 
treated groups, which is a normal part of the initial effects of LPS.  There were no 
significant differences in any groups for Hour 3.  Hour 4 posthoc tests revealed only 
one significant difference, between the heroin/saline treated group and the 
heroin/LPS treated group (p≤0.01).  By Hour 5, fever production had begun and the 
saline/LPS treated group was significantly elevated compared to the saline/saline 
(p≤0.01) and heroin/saline (p≤0.001) treated groups, while the heroin/LPS treated 
group only differed from the heroin/saline treated group (p≤0.001).  At Hour 6, the 
saline/LPS treated group continued to be significantly elevated compared to 
saline/saline (p≤0.001) and heroin/saline (p≤0.001) treated groups, as does the 
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heroin/LPS treated group (p≤0.001 for both).  Using posthoc tests, the saline/LPS 
treated group did not reach significance compared to the heroin/LPS treated group, 
but an a priori t-test revealed a significant difference between the two [t(22)=2.334, 
p≤0.05].  By Hour 7, the saline/LPS treated group was significantly different than all 
of the other groups:  saline/saline (p≤0.001), heroin/saline (p≤0.001), and 
heroin/LPS (p≤0.05).  The heroin/LPS treated group also differed significantly from 
the heroin/saline treated group (p≤0.01), and although nonsignificant results are 
generally not reported throughout this document, it is notable to point out that the 
heroin/LPS group, at Hour 7, does not differ significantly from the saline/saline 
treated group (p=0.637).  By Hour 8, the saline/LPS treated group no longer differs 
significantly from the heroin/LPS treated group, although it does still retain elevations 
compared to the saline/saline (p≤0.01) and heroin/saline (p≤0.01) treated groups.  
Figure 3.1 
 
β-endorphin protein analysis 
 Pilot studies (not shown) were performed to ensure validity of β-endorphin 
Western protocol.  The pilot results indicated that β-endorphin could be measured 
and differences between samples with differing amounts of protein could be 
determined.  For the present experiment, analysis was run on both β-endorphin and 
POMC, and means of density were examined.  There were no significant main 
effects of LPS or heroin and no interactions of LPS or heroin.  Figure 3.2 
 
RT-PCR 
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In the hypothalamus, 2 (heroin tx) x 2 (LPS tx) ANOVA found a main effect of 
LPS on levels of TNF-α [F(1,19)=17.64, p≤0.01], IL-1β [F (1,19)=10.68, p≤0.01], IL-6 
[F (1,19)=24.64, p≤0.001], iNOS [F (1,19)=13.66, p≤0.01], MCP-1 [F (1,19)=7.94, 
p≤0.05], IκBα [F(1,19)=20.26, p≤0.01], and COX-2 [F(1,19)=24.01, p≤0.01]. A main 
effect of heroin was found on levels of TNF-α [F (1,19)=7.01, p≤0.05], IL-1β [F 
(1,19)=10.67, p≤0.01], IL-6 [F (1,19)=20.17, p≤0.001], iNOS [F (1,19)=6.98, p≤0.05], 
IκBα [F(1,19)=16.16, p≤0.01] and COX-2 [F(1,19)=4.914, p≤0.05].  An interaction 
between LPS and heroin was found on levels of IL-6 [F(1,19)=23.01, p≤0.001], iNOS 
[F(1,19)=4.85, p≤0.05] and IκBα [F(1,19)=6.86, p≤0.05]. Posthoc tests revealed that 
the LPS/saline treated group was significantly elevated compared to all other groups 
in mRNA levels of TNF-α, IL-1β, IL-6, iNOS, IκBα, and COX-2, and the LPS/saline 
treated group differed significantly from the saline/saline and saline/heroin groups in 
levels of MCP-1. 
These results indicate that LPS induces a clear proinflammatory response in 
the hypothalamus which included all molecules measured, and with the exception of 
MCP-1, heroin suppresses each of these proinflammatory mediators to such an 
extent that they are no longer different than the saline/saline or heroin/saline treated 
groups.  Figure 3.3 and 3.4 
 
Discussion 
Major findings 
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 The results of these experiments clearly demonstrate that LPS induces 
proinflammatory mediator mRNA in the hypothalamus.  Heroin, in contrast, has a 
suppressive effect on production of proinflammatory mediators and COX-2, but not 
β-endorphin, in the hypothalamus after stimulation with LPS, and this is correlated 
with an attenuation of fever response.   
 
LPS induces proinflammatory mediator mRNA in the hypothalamus 
 In the present results, LPS significantly elevated all proinflammatory 
mediators in the hypothalamus.  This is consistent with the vast literature implicating 
proinflammatory mediators in fever production.  In most published studies examining 
proinflammatory mediators, protein is the measure used.  The results of the 
experiments in this chapter are complementary to these studies, as now it can be 
established that these proinflammatory are not only present in the hypothalamus, but 
also being actively produced in the hypothalamus.  Few studies thus far have used 
examination of mRNA to study these processes related to fever, and none have 
looked at multiple proinflammatory mediators.  This may seem a minute point, but 
there has been a great deal of discussion regarding the source of proinflammatory 
cytokines- whether they are trafficked in from the periphery or made within the 
hypothalamus (Maier et al., 1998b).  By now, most scientists favor the hypothesis 
that the cytokines are made within the hypothalamus due to the inability of cytokines 
to cross the blood brain barrier easily; however, there is little conclusive proof for 
this.  It is likely that there are a number of ways that the brain is signaled to begin 
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producing proinflammatory mediators, the most likely being that the vagal nerve 
transmits information from immune organs to stimulate proinflammatory cytokines in 
the brain (Blatteis, Sehic, & Li, 2000; Blatteis et al., 2005; Maier, Goehler, Fleshner, 
& Watkins, 1998a).  While the experiments presented here are not designed to rule 
out other mechanisms for cytokines to be present in the hypothalamus, the results 
do indicate that regardless of signal origin, cells within the hypothalamus are 
producing proinflammatory cytokines (TNF-α, IL-1β, IL-6, MCP-1) and other 
mediators (iNOS, Iκβα, COX-2), and these cytokines are correlated with the 
production of fever.  Further discussion into the potential pathways of signaling is 
found in Chapter 5. 
 
Heroin suppresses proinflammatory mediator mRNA in the hypothalamus 
 The results of this experiment show that heroin suppresses the mRNA of 
proinflammatory mediators in the hypothalamus.  Although Mayfield et al (1998) 
demonstrated that morphine suppresses plasma IL-1β and TNF-α, no studies to 
date have examined the effects of opiates on proinflammatory mediators within the 
hypothalamus. Together with the data from Chapter 2 and 4, this is the first study to 
evaluate the effects of opiates on in-brain cytokines.  The suppressive effects of 
heroin are very clear in all measures of the proinflammatory mediator mRNA data 
presented here.  While it has been established that opiates suppress peripheral 
immune responses and that suppression is at least partially mediated through neural 
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communications, this is the first to examine how heroin might alter immune 
responses within the brain and effects of these alterations.   
 
Lack of involvement of β-endorphin in alterations produced by heroin 
The lack of changes in β-endorphin in the hypothalamus was an unexpected 
effect, given that β-endorphin is likely to play a role in the production of fever and 
heroin users have altered β-endorphin responses in addition to altered infection 
rates.  However, upon closer examination, there may be reasonable explanations for 
this occurrence.  The first and most logical point to make is that this experiment only 
examined one time point, 8 hours post-treatment.  It is entirely possible that β-
endorphin increases are transient and occur prior to the timepoint examined.  
Another important point is that while the experiment was intended to study acute 
effects of heroin on fever production and related molecular mediators, the studies 
indicating that heroin users had an altered β-endorphin response were conducted on 
users that regularly abused heroin (Vescovi et al., 1992; Vescovi et al., 1989).  The 
chronic effects versus acute effects of heroin are quite different, and perhaps β-
endorphin responses are altered after chronic use of heroin as opposed to a more 
acute effect (Wang et al., 2008; Mocchetti et al., 1989).  That said, it is also possible 
that neither heroin nor LPS actually affect β-endorphin under any conditions, 
although that would argue against the number of studies implicating the µ opioid 
receptor in fever production as a response to LPS.  In fact, one study found that 
intracerebroventricular injection of LPS, IL-1β, or PGE2 increased staining for β-
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endorphin; it is not clear if the difference between systemic (as in this study) and 
intracerebral administration altered the outcome of β-endorphin (Tsai et al., 2003).  
Regardless, β-endorphin is not part of the traditional fever pathway, and it is unlikely 
that a lack of effect on β-endorphin would undermine any other effects seen in the 
molecules implicated in the traditional fever pathway such as cytokines and PGE2.   
 
Suppression of fever response by heroin 
 The ability of heroin to suppress the proinflammatory mediators in the 
hypothalamus is reflected in the concurrent attenuation of fever response.  We have 
established that the hyperthermia induced by heroin is not related to production of 
proinflammatory mediators in the hypothalamus, and that the administration of 
heroin attenuates the production of fever in response to LPS.  It can be concluded, 
then, that the attenuation of fever is not directly related to the earlier hyperthermia; 
that is, the brief hyperthermia induced by heroin does not exhaust the potential to 
produce proinflammatory cytokines and prevent fever in this manner.  However, the 
suppression of proinflammatory cytokines by heroin during fever is quite apparent in 
both the cytokine (TNF-α, IL-1β, IL-6, MCP-1) levels seen as well as the potential for 
PGE2 induction (COX-2).  The disruption of this pathway predictably results in an 
inhibition of fever response.  The lack of fever response in rats treated with heroin 
may be one mechanism through which heroin users are less able to fight off 
infection.  It also represents the importance of proinflammatory responses in the 
brain, and highlights the consequences of suppression of these responses.  
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Conclusion 
 The results presented here represent the first efforts to determine the 
consequences of opiates on the immune response within the brain.  These results 
show that heroin suppresses brain proinflammatory mediator mRNA in the 
hypothalamus, and a concurrent suppression of fever is also seen.  Future studies to 
elaborate on these results and address the potential mechanisms through which 
opiates might exert these effects are discussed further in Chapter 5. 
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Table 2.  Significance values by group for the duration of the 8-hour experiment 
measuring core body temperature after 1mg/kg heroin or saline and 1mg/kg LPS or 
saline treatment. ** t test comparing saline/LPS and heroin/LPS treated groups 
revealed a significant difference (p=0.029).  
    Baseline Hour 0 Hour 1 Hour 2 Hour 3 
saline/saline             
  heroin/saline 0.902 0.541 0.037 0.167 0.858 
  saline/LPS 0.655 0.523 0.535 0.001 0.527 
  heroin/LPS 0.949 0.934 0.102 0.685 0.928 
heroin/saline             
  saline/saline 0.902 0.541 0.037 0.167 0.858 
  saline/LPS 0.962 0.039 0.463 0.001 0.935 
  heroin/LPS 0.999 0.212 0.969 0.739 0.484 
saline/LPS             
  saline/saline 0.655 0.523 0.535 0.001 0.527 
  heroin/saline 0.964 0.039 0.463 0.001 0.935 
  heroin/LPS 0.920 0.855 0.737 0.001 0.196 
heroin/LPS             
  saline/saline 0.949 0.934 0.102 0.685 0.928 
  heroin/saline 0.999 0.212 0.969 0.739 0.484 
  saline/LPS 0.920 0.855 0.737 0.001 0.196 
    Hour 4 Hour 5 Hour 6 Hour 7 Hour 8 
saline/saline             
  heroin/saline 0.153 0.332 0.922 0.132 0.849 
  saline/LPS 0.981 0.004 0.001 0.001 0.030 
  heroin/LPS 0.440 0.082 0.001 0.637 0.581 
heroin/saline             
  saline/saline 0.153 0.332 0.922 0.132 0.849 
  saline/LPS 0.280 0.001 0.001 0.001 0.003 
  heroin/LPS 0.003 0.001 0.001 0.006 0.157 
saline/LPS             
  saline/saline 0.981 0.004 0.001 0.001 0.030 
  heroin/saline 0.280 0.001 0.001 0.001 0.003 
  heroin/LPS 0.231 0.605 0.073** 0.033 0.371 
heroin/LPS             
  saline/saline 0.440 0.082 0.001 0.637 0.581 
  heroin/saline 0.003 0.001 0.001 0.006 0.157 
  saline/LPS 0.231 0.605 0.073 0.033 0.371 
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Figure 3.1    Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS 
(1mg/kg) or saline.  Sacrifice occurred 8 hours after treatment.  Data is represented 
as means by treatment group with standard error of means (SEM).  Body 
temperature was measured via 1 minute samples taken over 5 minutes and 
averaged per rat at every hour interval.   * denotes significance of at least p≤0.05.   
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Figure 3.2    Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS 
(1mg/kg) or saline.  Sacrifice occurred 8 hours after treatment.  Data is represented 
as means by treatment group with standard error of means (SEM).  β endorphin and 
POMC were measured from protein derived from dissected hypothalamus via 
Western blot.  (a)  Picture of actual β-endorphin Western blot.  The top row 
represents POMC while the lower row indicates β-endorphin.  Density was 
quantitated by computer and is expressed by a ratio of total density by total area for 
POMC (b) and β-endorphin (c).  Data is represented as means by treatment group 
with standard error of means (SEM). 
 
a.   
 
 
 
 
 
 
 
 
 
 
 
 
 
sa
lin
e/
sa
lin
e
he
ro
in
/s
al
in
e
sa
lin
e/
LP
S
he
ro
in
/L
P
S
0
10000
20000
30000
40000
D
e
n
s
it
y
sa
lin
e/
sa
lin
e
he
ro
in
/s
al
in
e
sa
lin
e/
LP
S
he
ro
in
/L
P
S
0
10000
20000
30000
40000
50000
D
e
n
s
it
y
b.
c.
51 
 
Figure 3.3    Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS 
(1mg/kg) or saline.  Sacrifice occurred 8 hours after treatment.  Data is represented 
as means and SEM of mRNA ratios compared to housekeeping gene CANX as 
measured through RT-PCR.  * denotes significance of at least p≤0.05.  The following 
graphs represent the mRNA levels measured in the hypothalamus.  (a)  TNF-α (b) 
IL-1β (c) iNOS (d) IL-6 (e) MCP-1  
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Figure 3.4    Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS 
(1mg/kg) or saline.  Sacrifice occurred 8 hours after treatment.  Data is represented 
as means and SEM of mRNA ratios compared to housekeeping gene CANX as 
measured through RT-PCR.  * denotes significance of at least p≤0.05.  The following 
graphs represent the mRNA levels of (a) IκBα and (b) COX-2 measured in the 
hypothalamus.   
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 Chapter 4  
Heroin suppresses LPS-induced proinflammatory mediators in the 
hippocampus and subsequent behavioral depression. 
 
Introduction 
Proinflammatory mediators such as TNF-α, IL-1β, iNOS, IL-6, and MCP-1 are 
commonly found preferentially in the hippocampus after various types of immune 
stimulation (Semmler, Okulla, Sastre, Dumitrescu-Ozimek, & Heneka, 2005; Wolff et 
al., 2009).  This is likely to be a result of high numbers of microglia in the 
hippocampus (Lawson, Perry, Dri, & Gordon, 1990).  Immune activation induces a 
change in motivational state that results in a decrease in activity requiring increased 
proinflammatory mediators as a vital part of this process.  In the field of 
neurobiology, the hippocampus is a brain region typically associated with learning 
and memory.  The presence and synthesis of these proinflammatory mediators in 
the hippocampus results in learning and memory functions normally regulated by 
this region being largely disrupted.  There is a great deal of overlap between the 
literature implicating proinflammatory mediators in the hippocampus with 
hippocampally-dependent learning impairments and a reduction in activity as a 
sickness behavior.    
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Learning and memory deficits during immune activation are well documented.  
The specificity of the hippocampal inflammation and its detrimental effects on 
learning and memory are seen in a set of experiments in which rats administered 
LPS during the consolidation period after conditioning displayed an impairment in 
learning for hippocampally dependent context conditioning but not for hippocampus-
independent auditory fear conditioning (Pugh et al., 1998; Rachal, Fleshner, 
Watkins, Maier, & Rudy, 2001).  In these experiments, administration of IL-1 
receptor antagonist reversed the impairments produced by LPS on context 
conditioning, indicating a causal role for IL-1β.  However, IL-1β is not the only 
proinflammatory mediator linked to increases during immune activation in the 
hippocampus and subsequent learning and memory deficits.  In addition to 
proinflammatory cytokines, iNOS is preferentially increased in the hippocampus 
compared to a number of other brain regions (Semmler et al., 2005).  IL-6 also plays 
an important role that is specific to brain inflammatory responses.  IL-6 knockout 
mice display a normal TNF-α and IL-1β response in the peripheral system after LPS 
stimulation; however, these mice have an attenuated IL-1β and TNF-α response in 
hippocampal tissue, indicating the necessity of IL-6 in order for this pathway to come 
to completion (Sparkman et al., 2006).  In addition to the molecular alterations seen 
in these mice, the IL-6 knockout mice did not demonstrate deficits in working 
memory after LPS treatment, contrary to their IL-6 (+/+) counterparts.  Additionally, 
interleukin-10 (IL-10), a typically anti-inflammatory cytokine, deficit mice had a 
prolonged inflammatory response in the hippocampus and a more severe deficit in 
ability to integrate new information compared to mice with normal IL-10 responses 
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(Richwine et al., 2009).  IL-1β and TNF-α also decrease glutamatergic uptake in the 
hippocampus as well as cause an impairment of long-term potentiation (LTP), which 
suggests a potential mechanism for these learning impairments (Tanaka et al., 2006; 
Hauss-Wegrzyniak, Lynch, Vraniak, & Wenk, 2002; Cunningham, Murray, O'Neill, 
Lynch, & O'Connor, 1996).   
Aging causes increased proinflammatory mediators in the hippocampus as an 
independent effect, and these effects are potentiated by LPS injection, causing 
increased IL-1β up to 24 hours later and behavioral depression; these effects can be 
ameliorated by antagonizing IL-1β (Abraham & Johnson, 2009).   A prolonged 
inflammatory response to immune challenge has been seen in aging rodents in a 
number of experiments, and appears to be specific to the hippocampus and 
hippocampally-dependent tasks such as context and spatial learning (Barrientos, 
Watkins, Rudy, & Maier, 2009; Barrientos et al., 2009).  Increased IL-1β in the 
hippocampus is also seen after LPS administration that disrupted working memory in 
aged rats (Chen et al., 2008).   
The learning and memory impairments produced by an inflammatory 
response in the hippocampus have clearly been demonstrated.  However, simply 
impairing learning abilities is probably not in itself an evolutionarily adaptive behavior 
to exhibit during illness and is more likely to be a side effect of initiation of a more 
adaptive behavior.  Behavioral depression, demonstrated by an avoidance of social 
contact and general activity, is an adaptive behavior to exhibit during illness.  The 
lack of activity allows more energy reserves to be directed towards activating the 
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immune system to effectively clear the invading infection from the body, as well as to 
increase body temperature.    
The cytokines and other proinflammatory mediators shown to produce 
learning and memory deficits are the same as those associated with behavioral 
depression during sickness.  Given that, there is predictably a significant overlap 
between learning deficits and production of sickness behaviors.  The production IL-
1β, in particular, has been linked to sickness behavior (Campisi et al., 2003).  IL-6 
and TNF-α are also believed to play a role in sickness behavior ilicited from the 
hippocampus, although the roles of these cytokines are not as well defined as IL-1β 
(Henry et al., 2008; Anisman et al., 2008; Pauli et al., 1998).  Similar to learning and 
memory deficits, aged mice have a more robust behavioral sickness response to 
LPS which can be reversed with central administration of IL-1 receptor antagonists 
(Abraham et al., 2009).  Prolonged cytokine production in the hippocampus due to a 
deficiency of the anti-inflammatory cytokine IL-10 was also correlated with longer 
demonstration of sickness behavior (Richwine et al., 2009).  LPS induces increased 
levels of IL-1β and IL-6 in the hippocampus and cortex that is correlated with 
behavioral depression; reversal of these cytokines and behavioral depression can be 
achieved with inhibition of microglial activation, indicating both of these effects are 
dependent upon activation of microglia induced by LPS (Henry et al., 2008).  
Although the connection is not as thoroughly established as fever is with the 
hypothalamus, proinflammatory cytokines are an imperative part of the pathway to 
induce behavioral depression, and the hippocampus has been implicated as a key 
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region for this phenomenon.  The following experiments help to further establish the 
role of the hippocampus in behavioral depression as measured by activity. 
Opiates such as morphine and heroin have been shown to suppress 
peripheral proinflammatory cytokines, an effect that may be related to the increased 
infection rates in opiate users.  However, no studies have examined the effects of 
systemic opiates on brain proinflammatory cytokines (except those already 
presented in this dissertation), particularly in the context of the hippocampus and 
behavioral depression.  The purpose of the following studies is to examine how 
heroin affects the cytokine portion of the sickness pathway in the hippocampus, and 
consequences on behavioral depression.  The following experiment consisted of 
administration of concomitant LPS or saline and heroin or saline and examination of 
proinflammatory mRNA in the brain 8 hours post-treatment.  This experiment 
demonstrated that heroin has an inhibitory effect on the induction of proinflammatory 
mediator mRNA by LPS in the hippocampus, as well as a suppression of behavioral 
depression.  Since there is less research regarding the hippocampus and behavioral 
depression, cortex and striatum tissue was also examined for reference, although 
direct comparisons are not possible between the tissues due to limitations in PCR 
runs.  
 
Materials and Methods 
Animals   
 Animals were housed under the same conditions and approvals as listed in 
Chapter 2.  There were a total of 48 rats used for these experiments. 
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Surgical procedures 
 Surgical procedures were the same as listed previously in Chapter 2 for 
implantations of biotelemetry devices.  As before, the rats were allowed at least one 
week to recover before further experimental procedures were conducted.   Home 
cages were placed and kept on top of the biotelemetry receivers.   
 
Drug administration   
 All injections of heroin, LPS, or saline were given subcutaneously on the 
abdomen.  LPS was E. coli derived and purchased from Sigma-Aldrich (St. Louis, 
MO).  
 
Dissection procedures 
 Immediately following cervical dislocation, brains were extracted rapidly 
dissected immediately.  Target tissues were dissected using Paxinos and Watson as 
a guide (Paxinos et al., 2005).  Half of the subjects were selected for mRNA 
analysis, while the other half were designated for protein analysis, spread evenly 
amongst all the groups.  Tissues for mRNA analysis were stored in RNAlater 
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(Ambion, Austin, TX) at -80°C until processed for RNA extraction.  Tissues for 
protein analysis were stored in an anti-proteinase buffer at -80°C.   
 
Real time reverse transcription polymerase chain reaction (RT-PCR) 
          The same procedures as reported previously were used to determine mRNA 
levels of proinflammatory mediators in the hypothalamus.  Total RNA was extracted 
from each of these brain tissues using Tri-Reagent (Molecular Research Center, 
Inc., Cincinnati, OH), following modified methods described by (Chomczynski et al., 
1987).  Quantification was performed as described before and cDNA was created for 
RT-PCR analysis.  The cDNA was then measured in individual runs of RT-PCR as 
previously described.  The target molecules for this analysis included the following: 
TNF-α, IL-1β, iNOS, IL-6, MCP-1, Ikβα, and COX-2.   
 
Data and Statistical Analysis 
 Statistical analysis.   All analyses were performed using SPSS v17.0.  
Significance was set at p=0.05.  If significant results for Levene’s test of equality for 
variances were noted, equal variances were not assumed for results.   Tukey’s 
posthoc tests were used when main effects or interactions were found to be 
significant. 
 RT-PCR.  Data were converted to ratios based on the housekeeping gene 
CANX to ensure the most accurate comparisons.  Housekeeping gene CANX was 
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assessed using the raw copy numbers to ensure that no significant differences were 
found between groups in this important baseline measure.  A 2 (LPS treatment) x 2 
(heroin treatment) ANOVA was run for each target molecule. 
 Activity.  Activity data was transmitted and recorded by a nearby computer in 
one minute bins.  Bins were summed over each hour for each rat.  A time * LPS * 
heroin mixed design ANOVA was run with time as a repeating measure and LPS 
and heroin as independent variables.  Another 2 (LPS treatment) x 2 (heroin 
treatment) ANOVA was also run to determine overall main effects and interactions of 
LPS and heroin independent of time.  This analysis consists of binned data over the 
entire 8 hour time period that occurred between treatment and sacrifice.   
 
Results 
Activity 
To determine if there was an interaction with time for the measure of activity, 
a repeated measures ANOVA was used with summed bins of activity per hour for 
each rat.  LPS and heroin treatments were independent variables while time (with 9 
time points) served as a repeated measure.  For this analysis, the interaction 
between time * LPS * heroin was significant [F(8,344)=2.720, p≤0.01].  Additional 
analysis indicated a between subjects main effect of LPS [F(1,20)=89.690, p≤0.001] 
and a significant interaction of heroin and LPS [F(1,20)=27.946, p≤0.001].  For full 
posthoc test results, refer to Table 3 (page 71). To summarize the most striking 
findings, at Hour 1, the heroin/saline and heroin/LPS treated groups were 
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significantly decreased compared to the saline/saline (p≤0.001, p≤0.001) and 
saline/LPS (p≤0.001, p≤0.001) treated groups.  By Hour 2, the saline/LPS treated 
group was significantly decreased compared to the saline/saline (p≤0.01) treated 
group.  At Hour 3, the saline/LPS treated group was significantly less than the 
saline/saline (p≤0.001), heroin/saline (p≤0.001), and heroin/LPS (p≤0.001) treated 
group.  At Hour 4, the saline/LPS treated group was significantly decreased in 
activity compared to the saline/saline (p≤0.001), heroin/saline (p≤0.001), and 
heroin/LPS (p≤0.01) treated groups, while the heroin/LPS treated group 
demonstrated significantly less activity than the saline/saline (p≤0.01) and the 
heroin/saline (p≤0.01) treated groups, but was actually increased in activity 
compared to the LPS/saline (p≤0.01) treated group.  At Hour 5, the saline/LPS 
treated group continued to show decreased activity compared to saline/saline 
(p≤0.001) and heroin/saline (p≤0.05) treated groups.  At Hour 6, the saline/LPS 
treated group was significantly lower than the heroin/saline (p≤0.01) and heroin/LPS 
(p≤0.01) treated groups, but only trended towards significance compared to the 
saline/saline (p≤0.06) treated groups.  At Hour 7, the saline/LPS treated group 
displayed decreased activity compared to all groups, saline/saline (p≤0.01), 
heroin/saline (p≤0.01), and heroin/LPS (p≤0.05) treated groups.  By Hour 8, the 
saline/LPS treated group was still lowered compared to saline/saline (p≤0.001) and 
heroin/saline (p≤0.001) treated groups, but did not reach significance compared to 
heroin/LPS treated groups.   
In addition to the time-dependent effects summarized above, there was a 
significant main effect of LPS [F(1,43)=100.60, p≤0.001) as well as a significant 
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interaction of heroin * LPS [F(1,43)=34.747, p≤0.001).  Posthoc tests indicated that 
all four groups were significantly different from each other in the measure of activity:  
saline/saline treated group was significantly higher than heroin/saline (p≤0.001), 
saline/LPS (p≤0.001), and LPS/heroin (p≤0.001) treated groups; the heroin/saline 
treated group was significantly higher than the saline/LPS (p≤0.001) and heroin/LPS 
(p≤0.05) treated group; and the LPS/heroin treated group was significantly increased 
compared to the saline/LPS treated group (p≤0.01).  To summarize, the groups 
listed in order of greatest amount of activity to the least amount of activity are as 
follows:  saline/saline, heroin/saline, heroin/LPS, and saline/LPS.  Figure 4.1 
 
RT-PCR   
Hippocampus.  In the hippocampus, there was a significant effect of LPS on 
IL-1 β [F(1, 23)=11.923, p≤0.01], MCP-1 [F(1,23)=9.155, p≤0.01], and IκBα 
[F(1,23)=14.733, p≤0.001], while iNOS trended towards a main effect of LPS but did 
not reach significance [F(1,23)=4.077, p=0.057].  TNF-α mRNA levels demonstrated 
a significant main effect of LPS [F(1,23)=16.030, p≤0.001] and an interactive effect 
of LPS*heroin [F(1,23)=4.702, p≤0.05].  IL-6 mRNA levels demonstrated main 
effects in both LPS [F(1,23)=17.240, p≤0.001], heroin [F(1,23)=10.572, p≤0.01], and 
an interactive effect of LPS * heroin [F(1,23)=11.307, p≤0.01].  Posthoc tests 
revealed that the mRNA levels of TNF-α and IL-6 in the saline/LPS treated group 
were significantly increased compared to saline/saline (p≤0.01, p≤0.001, 
respectively), heroin/saline (p≤0.01, p≤0.001), and heroin/LPS (p≤0.05, p≤0.001) 
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treated groups.  MCP-1 and IκBα mRNA were significantly elevated in the 
saline/LPS treated group compared to saline/saline (p≤0.05, p≤0.01, respectively) 
and heroin/saline treated groups (p≤0.05, p≤0.01), but not compared to the 
heroin/LPS treated group, indicating the inhibition of MCP-1 was not sufficient to 
significantly distinguish the LPS treated groups from one another based on heroin 
treatment.  Figure  4.2 and 4.3 
Cortex.  In the cortex, there was a significant effect of LPS on TNF-α 
[F(1,23)9.517, p≤0.01], IL-6 [F(1,23)=11.910, p≤0.01], and IκBα [F(1,23)=10.471, 
p≤0.01].  There were no significant main effects of heroin nor were there LPS * 
heroin interactions among any molecules measured.  Posthoc tests revealed a 
significant difference between the heroin/saline treated group and the saline/LPS 
treated group in TNF-α mRNA expression (p≤0.05), and the LPS/saline treated 
group was significantly increased in IL-6 and IκBα mRNA levels compared to both 
the saline/saline (p≤0.01, p≤0.05) and heroin/saline (p≤0.01, p≤0.05) treated groups 
compared to the LPS/saline treated group.  Figure 4.4 and 4.6 
Striatum.  In the striatum, there was a main effect of LPS [F(1,23)=12.592, 
p≤0.005), main effect of heroin [F(1,23)=6.160, p≤0.05), and an interactive effect of 
LPS * heroin [F(1,23)=16.011, p≤0.001] in only the measure of MCP-1 mRNA.  
Posthoc tests of MCP-1 mRNA expression revealed that the LPS/saline treated 
group was increased significantly from the saline/saline treated group (p≤0.001), 
heroin/saline treated group (p≤0.05), and heroin/LPS treated group (p≤0.001).  
There was an interactive effect of LPS * heroin on IL-1β mRNA expression 
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[F(1,23)=4.446, p≤0.05]; posthoc tests revealed that the saline/saline treated group 
was significantly lower  than the LPS/saline treated group (p≤0.05).  There were no 
other significant differences in the striatum.  Figure 4.5 and 4.6 
 
Discussion 
Major findings  
 LPS treatment increased the proinflammatory mediator expression of TNF-α, 
IL-1β, MCP-1, IL-6 and IκBα mRNA in the hippocampus, as shown by the 
saline/LPS treated group compared to both the saline/saline and heroin/saline 
treated groups.  In contrast, for the same comparison, the cortex only showed 
increased IL-6 and IκBα in response to LPS, and the striatum only showed increased 
MCP-1.  These are the first to examine this selection of proinflammatory mediator 
mRNA in comparison to each other and in these specific brain regions.  The 
hippocampus showed an increased inflammatory response, as indicated by the 
number of mediators that were affected by LPS treatment, is consistent with 
published findings that the hippocampus is a particularly immunoresponsive area in 
comparison to most other brain regions.   
 To date there are no published studies examining the effects of opiates such 
as morphine and heroin on brain proinflammatory mediators.  These results are the 
first to address this issue, and clearly demonstrate that in the hippocampus, some 
proinflammatory mediators are significantly affected by co-administration of heroin 
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with LPS.  Specifically, TNF-α and IL-6 are decreased with the administration of 
heroin in LPS-treated rats compared to those that do not receive heroin in addition to 
the LPS treatment.   
 A final finding is that, as expected, LPS treatment decreased general activity 
in rats in a measure of behavioral depression.  Heroin by itself decreased activity 
slightly but significantly, which was due to the immediate effects of heroin in the first 
two hours post-treatment.  The heroin/LPS treated group demonstrated activity 
levels that totaled between those of saline/LPS treated group and the heroin/saline 
treated group.  Analysis indicated that while the heroin effects in the LPS/heroin 
group are still present, the effects of LPS in this group were at least partially 
mitigated. 
 
TNF-α and IL-6 in behavioral depression 
 Considering the support in the literature for the role of IL-1β in the 
hippocampus and behavioral depression, it was somewhat surprising that heroin did 
not exert significant effects on IL-1β mRNA while still inhibiting behavioral 
depression.  However, the role of IL-1β may be subject to a bias based upon 
availability of knowledge regarding this cytokine, which has been known for much 
longer than most other proinflammatory cytokine and studied at length.  TNF-α and 
IL-6 mRNA were significantly suppressed in the heroin/LPS treated group compared 
to the saline/LPS treated group, making either or both of them more likely targets for 
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the inhibition of behavioral depression also see in the heroin/LPS treated group 
compared to the saline/LPS treated group.  Although TNF-α has been researched 
extensively, there are few, if any, studies implicating it causally in behavioral 
depression and intrahippocampal injections of TNF-α do not induce behavioral 
depression (Pauli et al., 1998).  Thus, it is unlikely that TNF-α is the primary cytokine 
responsible for the alterations seen between the saline/LPS and heroin/LPS treated 
groups.   
 The results of these experiments indicate a role of IL-6, which may have been 
initially underestimated in this behavior.  IL-6 is a later-induced cytokine compared to 
IL-1β, and this experiment was designed to examine later timepoints (Laye et al., 
1994).  It may be that with the extended time (8 hours post-treatment) used in these 
experiments, IL-6 was a more integral part of the pathway leading to behavioral 
depression, and reversal of IL-6 production by heroin led to an amelioration of 
behavioral depression.  Given the significant overlap between behavioral depression 
and learning, it is worth consideration that IL-6 deficient mice were resistant to LPS-
induced impairments in the Morris water maze, a spatial task dependent upon the 
hippocampus, and had reduced IL-1β and TNF-α levels in the brain while retaining 
normal levels in peripheral plasma (Sparkman et al., 2006).  This study is intriguing 
in light of the results presented above, suggesting IL-6 is necessary for the brain to 
produce or sustain IL-1β and TNF-α and that this may account for reversal of 
hippocampal impairments.  However, it is important to note that the results in this 
dissertation do not address learning and memory impairments specifically, as well as 
the fact that IL-1β levels were not suppressed in the heroin/LPS treated animals as 
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one might expect if a lack of IL-6 were preventing IL-1β production, although IL-1β 
levels were not significantly elevated by LPS regardless. A more closely related 
published experiment indicated that IL-6 deficient mice did not exhibit reduced social 
activity, a facet of behavioral depression, when given LPS, compared to their wild 
type counterparts (Mingam et al., 2008).  Likewise, IL-1 deficient mice also displayed 
attenuation of reduced social exploration, body weight and immobility to LPS 
(administered either systemically or intracerebroventricularly) (Bluthe, Michaud, Poli, 
& Dantzer, 2000).  Anti-serum to IL-6 also inhibits behavioral depression after LPS 
treatment, while anit-sera to TNF-α and IL-1β had no such effect (Harden et al., 
2006).  Collectively, these previous studies suggest that production of IL-6 in the 
hippocampus is an integral part of the inflammatory response carried out in that 
brain region, and the results from this study support this hypothesis by 
demonstrating that the lack of LPS-induced IL-6 mRNA in the hippocampus is 
correlated with a reduction of behavioral depression induced by LPS.   
 
Intermediates of cytokines and behavior 
While it is apparent that proinflammatory cytokines such as IL-1β produce 
deficits in hippocampally-dependent learning, the cytokines themselves cannot 
directly induce behavioral changes.  One potential intermediate between cytokines 
and behavior is PGE2.  Inhibition of COX-2 reverses the learning impairments 
caused by IL-1β, indicating a potential role for PGE2 in the hippocampal disruptions 
(Hein et al., 2007).  However, the role of PGE2 in the hippocampus is not nearly as 
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established as it is in the hypothalamus, and it is possible that proinflammatory 
mediators can bypass this step.  Interestingly, behavioral depression has also been 
investigated as a result of glycoprotein 120, an envelope protein on the human 
immunodeficiency virus (HIV) that is believed to be one of the main inflammatory 
agents of HIV.  Intracerebrally injected gp120 induces a number of sickness 
behaviors, including behavioral depression and fever, which were associated with 
increased IL-1β and PGE2 in both hippocampus and hypothalamus.  However, 
neither prevention of PGE2 synthesis and antagonizing IL-1β centrally affected the 
behavioral depression seen with gp120, although it did prevent the fever response 
(Barak et al., 2002a; Barak et al., 2002b).  These experiments suggest that although 
cytokines and prostaglandins are involved in the process of producing behavioral 
depression, there are other variables such as other cytokines like IL-6 that can take 
over the process. 
Clearly, neurons are an important part of this process, and specifically, 
serotonergic transmission is vital to the behavioral effects of proinflammatory 
mediators in the hippocampus, although there is some evidence for norepinephrine 
also being involved in these processes.  Interestingly, serotonin is a key 
neurotransmitter in controlling activity via projections to many motor areas of the 
brain (Jacobs & Fornal, 1995).  Measurement of serotonin via microdialysis in the 
hippocampus in vivo has shown that LPS causes increased hippocampal serotonin 
release as well as norepinephrine to a lesser degree (Lacosta, Merali, & Anisman, 
1999; Linthorst et al., 1998).  Systemic IL-1β and IL-6 both increase serotonin 
activity in the hippocampus (Zalcman et al., 1994).  Minocycline, a microglial 
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inhibitor, reduced IL-1β, IL-6, and indoleamine 2,3 dioxygenase (commonly used 
measure for serotonin activity) in the hippocampus after LPS treatment and also 
suppressed sickness behavior, which indicates the cytokines and serotonin are part 
of the pathway involved in sickness behavior elicited from the hippocampus (Henry 
et al., 2008).  Importantly, serotonin increases in healthy, active rats and decreases 
during rest and sleeping; however, when an immune challenge is present, serotonin 
release is increased while activity is decreased (Linthorst et al., 1994).  Serotonin 
receptors are also increased in the hippocampus after chronic administration of IL-
1β (Anisman et al., 2008).  Interestingly, IL-6 is implicated in increasing serotonin 
turnover in the hippocampus in a non- PGE2 dependent manner (Wang & Dunn, 
1998; Barkhudaryan & Dunn, 1999).  This supports our findings that IL-6 levels 
inversely correlate with activity, while COX-2, an indicator of PGE2 activity, does not.  
Serotonin dose-dependently suppresses LTP in hippocampal slices, providing a 
potential mechanism through which proinflammatory mediators can impair LTP, as 
noted above, and thus impair learning ability (Staubli & Otaky, 1994; Hauss-
Wegrzyniak et al., 2002).  While these experiments do not specifically address 
serotonin, given the evidence available, it seems likely that heroin, by suppression of 
IL-6 and TNF-α, would also suppress serotonin, resulting in the alleviation of 
behavioral depression that was clearly measured in the experiments above.   
 
Conclusion 
The experiments completed in this chapter are the first to utilize RT-PCR to 
comprehensively examine proinflammatory mediators in hippocampal-specific 
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responses to LPS stimulation.  Moreover, these are the very first studies to begin to 
inspect the relationship between opiates and proinflammatory mediators in the brain 
and subsequent sickness behaviors.  In addition to the many risk factors opiates 
users are known to have in terms of infections, these data indicate that opiates may 
also prevent adaptive sickness behaviors as a result of altered proinflammatory 
mediator responses in the brain.  Although there are important implications for 
heroin induced suppression of IL-6 and TNF-α in the hippocampus, it may prove that 
the use of heroin to suppress these events is a useful tool for understanding the 
complex pathways involved in neuroimmune communication and sickness 
behaviors, which are discussed further in the next chapter.   
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Table 3.  Significance values by group for the duration of the 8-hour experiment 
measuring general activity after 1mg/kg heroin or saline and 1mg/kg LPS or saline 
treatment.   
    Baseline Hour 1 Hour 2 Hour 3 Hour 4 
saline/saline             
  heroin/saline 0.967 0.001 0.001 0.696 0.963 
  saline/LPS 0.914 1.000 0.003 0.001 0.001 
  heroin/LPS 0.878 0.001 0.001 0.833 0.002 
heroin/saline             
  saline/saline 0.967 0.001 0.001 0.696 0.963 
  saline/LPS 0.667 0.001 0.703 0.001 0.001 
  heroin/LPS 0.608 0.993 0.967 0.994 0.007 
saline/LPS             
  saline/saline 0.914 1.000 0.003 0.001 0.001 
  heroin/saline 0.667 0.001 0.703 0.001 0.001 
  heroin/LPS 1.000 0.001 0.421 0.001 0.005 
heroin/LPS             
  saline/saline 0.878 0.001 0.001 0.833 0.002 
  heroin/saline 0.608 0.993 0.967 0.994 0.007 
  saline/LPS 1.000 0.001 0.421 0.001 0.005 
    Hour 5 Hour 6 Hour 7 Hour 8   
saline/saline             
  heroin/saline 0.116 0.773 0.999 0.328   
  saline/LPS 0.001 0.065 0.002 0.001   
  heroin/LPS 0.014 0.832 0.887 0.001   
heroin/saline             
  saline/saline 0.116 0.773 0.999 0.328   
  saline/LPS 0.029 0.004 0.003 0.001   
  heroin/LPS 0.808 0.999 0.929 0.001   
saline/LPS             
  saline/saline 0.001 0.065 0.002 0.001   
  heroin/saline 0.029 0.004 0.003 0.001   
  heroin/LPS 0.202 0.006 0.014 0.139   
heroin/LPS             
  saline/saline 0.014 0.832 0.887 0.001   
  heroin/saline 0.808 0.999 0.929 0.001   
  saline/LPS 0.202 0.006 0.014 0.139   
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Figure 4.1   Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS (1mg/kg) 
or saline.  Sacrifice occurred 8 hours after treatment.  Data is represented as means 
by treatment group with standard error of means (SEM).  Activity was measured by 
biotelemetry devices to indicate gross motor movement.   * denotes significance of 
at least p≤0.05.  (a)  Activity counts were summed over each hour for each rat and 
analyzed per treatment group over the 8 hours after treatment. (b) Activity counts 
were summed over the entire period of 8 hours post-treatment and compared to 
indicate treatment differences regardless of time.   
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Figure 4.2   Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS (1mg/kg) 
or saline.  Sacrifice occurred 8 hours after treatment.  Data is represented as means 
and SEM of mRNA ratios compared to housekeeping gene CANX as measured 
through RT-PCR.  * denotes significance of at least p≤0.05.  The following graphs 
represent the mRNA levels measured in the hippocampus.  (a)  TNF-α (b) IL-1β (c) 
iNOS (d) IL-6 (e) MCP-1  
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Figure 4.3   Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS (1mg/kg) 
or saline.  Sacrifice occurred 8 hours after treatment.  Data is represented as means 
and SEM of mRNA ratios compared to housekeeping gene CANX as measured 
through RT-PCR.  * denotes significance of at least p≤0.05.  The following graph 
represents the mRNA levels of (a) IκBα and (b) COX-2 measured in the 
hippocampus.   
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Figure 4.4   Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS (1mg/kg) 
or saline.  Sacrifice occurred 8 hours after treatment.  Data is represented as means 
and SEM of mRNA ratios compared to housekeeping gene CANX as measured 
through RT-PCR.  * denotes significance of at least p≤0.05.  The following graphs 
represent the mRNA levels measured in the cortex.  (a)  TNF-α (b) IL-1β (c) iNOS 
(d) IL-6 (e) MCP-1  
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Figure 4.5   Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS (1mg/kg) 
or saline.  Sacrifice occurred 8 hours after treatment.  Data is represented as means 
and SEM of mRNA ratios compared to housekeeping gene CANX as measured 
through RT-PCR.  * denotes significance of at least p≤0.05.  The following graphs 
represent the mRNA levels measured in the striatum.  (a)  TNF-α (b) IL-1β (c) iNOS 
(d) IL-6 (e) MCP-1  
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Figure 4.6  Rats were treated with heroin (1mg/kg, s.c.) or saline and LPS (1mg/kg) 
or saline.  Sacrifice occurred 8 hours after treatment.  Data is represented as means 
and SEM of mRNA ratios compared to housekeeping gene CANX as measured 
through RT-PCR.  * denotes significance of at least p≤0.05.  The following graphs 
represent the mRNA levels of (a) IκBα and (b) COX-2 measured in the cortex, and 
the mRNA levels of (c) IκBα and (d) COX-2 in the striatum.   
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Chapter 5 
 
General Discussion 
Primary Findings 
 The present series of experiments examined production of proinflammatory 
mediators in the brain as a result of heroin and/or LPS treatment as well as 
behavioral measures that correlate with brain proinflammatory mediators.  
Previously published work has clearly established that proinflammatory mediators 
are important to the production of sickness behaviors, particularly fever; however, 
none have addressed the relationship between opiates and brain proinflammatory 
mediators.   
 Chapter 2 examined the potential mechanism of heroin-induced 
hyperthermia, and concluded that this hyperthermic effect of heroin does not recruit 
the traditional fever pathway.  However, heroin does produce a marked increase in 
body temperature, despite the independence from increased proinflammatory 
mediators and insensitivity to the PGE2 synthesis inhibitor, indomethacin.   
 Chapter 3 presented studies that examined the effect of heroin on fever 
production and molecules involved in the traditional fever pathway.  These results 
are the first to examine a wide array of mRNA of LPS-induced proinflammatory 
mediators in the hypothalamus during fever, and the very first to address the effects 
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of opiates on hypothalamic production of proinflammatory mediators during fever as 
a potential mechanism for attenuation of fever.  Additionally, it was established that 
fever induced by LPS was impaired when heroin was also administered, presumably 
via the suppression of proinflammatory mediators by heroin. 
 Chapter 4 consisted of experiments demonstrating that like fever, heroin also 
inhibited production of proinflammatory mediators in the brain and this was 
consistent with the impairment of behavioral depression.  The hippocampus is not as 
well-established as the hypothalamus as an immunologically active region of the 
brain, although multiple studies have shown its involvement in directing behavioral 
depression in the event of an immune challenge.  These results contribute to those 
findings by demonstrating that LPS strongly induces proinflammatory mediators in 
this region, and heroin has an inhibitory effect on some of those proinflammatory 
mediators.  Interestingly, while the hypothalamus shows a robust effects in all 
measured proinflammatory mediators, the hippocampus shows a far more selective 
response which remains to be elucidated.   
 
Potential consequences of heroin-induced hyperthermia 
 While fever is an adaptive response to an immune challenge, increased body 
temperature overall is not likely to be beneficial, and is more likely to be detrimental 
to the health of the organism due to the high metabolic cost of sustaining a raised 
body temperature.  Hyperthermia (fever or not) enhances the ability of many immune 
cells to perform vital defense functions (Manzella et al., 1979; Sebag et al., 1977).  
However, when an immune challenge is not present, the cost of optimization of 
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these cells is unlikely to be a favorable outcome.  Overall, the ability of heroin to 
produce hyperthermia would impose a requirement of energy for little to no benefit to 
the organism.   
 There are a number of potential avenues of research to follow up on these 
findings.  First, there is the obvious question of mechanisms.  Many studies have 
already shown that the μ receptor is involved in opiate-induced hyperthermia and 
that this could potentially alter thermosensitive neuron sensitivity.  However, it would 
be interesting to determine exactly how this works- do the μ receptors reside on 
thermosensitive neurons directly, or do they require immune cells in some manner?  
What is the natural role of endogenous opioids such as β-endorphin in production of 
fever?  These are questions that could be answered regarding the hyperthermia.   
 A more intriguing avenue of research, in this author’s opinion, would be to 
determine how heroin-induced hyperthermia affects immune regulation in the rest of 
the body.  As noted above, hyperthermia has been shown to affect immune cell 
function.  However, these studies were done in vitro, which limits the application of 
their results.  In vivo determination of whether or not immune cells are affected by 
heroin-induced hyperthermia would help determine the downstream effects of this 
phenomenon.  Much of the support for fever as a beneficial response to microbial 
infection comes from disease outcome studies.  Since heroin-induced hyperthermia 
is not an infection-induced reaction, it would be interesting to see how the 
hyperthermia might affect non-disease outcomes more relevant to every day living 
as opposed to special circumstances (such as infection), particularly those 
associated with hypothalamic functions and homeostasis.   
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Heroin-induced hyperthermia and activity 
 Hyperthermia that is not fever is seen in a number of conditions, including 
neuroleptic malignant syndrome and sympathomimetic poisoning by cocaine or 
amphetamines.  All of these conditions involve the hypothalamus, but are not 
responsive to prostaglandin inhibition (Stitt, 1979).  These known hyperthermias can 
shed some light onto opiate-induced hyperthermia.  One line of thought is that 
heroin-induced hyperthermia is related to an increase in activity, similar to that seen 
in sympathomimetic poisoning as a result of overactivation of the sympathetic 
nervous system by cocaine or amphetamines (Halloran & Bernard, 2004; Rusyniak 
& Sprague, 2005).  Opiates do cause an increase in activity in mice (Yoo et al., 
2003); however, heroin in rats actually produces a substantial decrease in activity 
during the same time period that hyperthermia occurs (see Figure 4.1 and Table 3).  
Neuroleptic malignant syndrome occurs when an individual is taking drugs that block 
dopamine receptors, or when dopaminergic agents are suddenly withdrawn from the 
patient (usually Parkinson’s patients), resulting in muscle rigidity and hyperthermia 
that can be treated with dopamine agonists (Halloran et al., 2004; Newman, Grosset, 
& Kennedy, 2009; Rusyniak et al., 2005).  This indicates that an imbalance in 
dopamine results in hyperthermia when the imbalance is tilted in the direction of too 
little dopamine.  What we know about sympathomimetic poisoning and neuroleptic 
malignant syndrome indicates that heroin-induced hyperthermia is distinct from 
these conditions, as heroin reduces activity (differs from sympathomimetic 
poisoning) and increases dopamine (differs from neuroleptic malignant syndrome).     
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 Like hyperthermia, a lack of activity is reminiscent of sickness behaviors, yet 
does not seem to be a result of immune activation as seen by the lack of 
proinflammatory mediator mRNA in the hippocampus 90 minutes after heroin 
administration.  Also like hyperthermia, a decrease in activity is unlikely to be 
beneficial to the organism when not facing an immune challenge, and may represent 
a shift in motivation as seen in sickness behaviors that, instead of being 
advantageous, will cause behaviors that are inappropriate for the current 
environment.  The mimicry of sickness behaviors by heroin is unlikely to be adaptive 
when no immune challenge is present, and Chapters 3 and 4 address the potential 
problems that heroin presents in sickness behaviors when an immune challenge is 
on board. 
 
Heroin immunosuppression in the hypothalamus  
This is the first study to comprehensively examine proinflammatory mediators 
via RT-PCR in the hypothalamus as a result of systemic LPS administration, and the 
results are consistent with other studies suggesting the roles of the proinflammatory 
mediators suggested.  The effect of opiates on the proinflammatory mediators in the 
brain, however, is entirely original.  These very novel findings demonstrated that 
proinflammatory mediators are affected and likely involved in the suppression of 
fever; however, the experiments described in this dissertation are focused on 
establishing the effect, not addressing the mechanisms.  The logical next step, then, 
would be to determine those mechanisms through which opiates can suppress 
proinflammatory mediators.     
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Communication between peripheral immune activation and hypothalamus 
Heroin, as a μ agonist, could affect the immune response in a number of 
ways.  To understand the points in which heroin might affect, one must first consider 
the pathways of normal immune-neural communication.  There are many 
hypotheses regarding the communication that must occur for the immune system to 
signal to the brain that an immune challenge has occurred.   Although it is possible 
that cytokines from the bloodstream can signal to produce more cytokines in the 
brain, particularly in the hypothalamus, cytokines are relatively large molecules that 
cannot easily cross the blood brain barrier (Watkins, Maier, & Goehler, 1995).  There 
could also be specialized uptake mechanisms to aid cytokines in crossing the blood 
brain barrier, but these have not been found, although macrophage infiltration is also 
a possibility (Dunn, 2006).  Interestingly, the most prominent theory involves the 
vagal nerve and norepinephrine, although this does not exclude the possibility of 
other pathways also playing a role in peripheral immune communication to the brain 
(Maier et al., 1998a; Hansen et al., 2000).  Some of the most apparent changes that 
occur in the brain due to autonomic input during an immune reponse take place in 
the hypothalamus and the hippocampus, which is consistent with the regions 
implicated in producing sickness behaviors (Carlson, Felten, Livnat, & Felten, 1987).   
 The vagus nerve contains afferent projections to the brain from the peripheral 
organs via the nucleus of the solitary tract (NTS), which then projects to the locus 
coeruleus (LC) (Van Bockstaele, Peoples, & Telegan, 1999).  Specifically regarding 
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proinflammatory mediators and sickness behaviors, vagotomy prevents fever from 
peripherally administered IL-1β, but fever still occurs if PGE2 is introduced directly 
into the brain despite vagotomy (Milligan et al., 1997; Watkins et al., 1995).  The LC 
projects to many areas of the brain, most notably to the hypothalamus but also to the 
hippocampus, and has been implicated in providing the innervation with 
norepinephrine release in the hypothalamus (Dunn, 2006).  Peripheral stimulation of 
this pathway by proinflammatory cytokines causes a release of norepinephrine, and 
the norepinephrine projections to the hypothalamus, in turn, cause an increase in 
proinflammatory cytokine production there (Blandino, Jr., Barnum, & Deak, 2006; 
Zalcman et al., 1994).  Peripheral LPS treatment stimulates release of 
norepinephrine in the preoptic area of the hypothalamus, as confirmed by 
microdialysis studies (Lavicky & Dunn, 1995; Linthorst et al., 1998).  
Proinflammatory cytokine are produced in the brain by microglia, as indicated by the 
ability of the microglia inhibitor minocycline to decrease stress-induced IL-1β in the 
hypothalamus but not spleen (Blandino, Jr. et al., 2006).  These are the events that 
make up the most likely pathway of normal immune activation and fever production 
by the hypothalamus during an immune challenge.   
 
Potential mechanisms of opiates on immune-neural communication to the 
hypothalamus 
 Opiates have the potential to alter almost every step of this pathway from the 
initial signals to the vagus nerve to proinflammatory cytokine production in the 
hypothalamus.  Cultured monocytes (cells from which macrophages and microglia 
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are derived) treated with morphine have a suppressed TNF-α and IL-6 response to 
immune challenge, which is mediated by μ receptors (Bonnet, Beloeil, Benhamou, 
Mazoit, & Asehnoune, 2008).  This effect is likely due to μ receptors that are present 
on macrophages  (Chuang et al., 1995).  These mechanisms could have an effect 
on the initiation events to signal to the hypothalamus; that is, the vagus nerve would 
receive no or a diminished signal and subsequent pathways would respond (or not) 
accordingly.   
 While it is possible that opiates can inhibit immune responses by acting 
directly on peripheral immune cells via μ receptors, it is unlikely that this can account 
for all of the effects of opiates.  One study indicated that μ antagonists administered 
directly into the brain increased serum IL-6 (Bertolucci, Perego, & De Simoni, 1997).  
This indicates that the μ receptor plays an integral role in altering cytokine levels 
(albeit peripheral cytokine levels) via a central mechanism.  One might infer that μ 
agonists would have the opposite effect and decrease IL-6 in the serum, and this 
finding could potentially extend to the central cytokines as well.  Unfortunately, while 
it is common for investigators to measure peripheral cytokines, brain cytokines and 
other proinflammatory mediators have not been examined in respect to effects of μ 
receptor influence.  Using the knowledge presented above, we must then speculate 
on how central μ receptors may influence brain proinflammatory mediator 
production.   
 After the immune cells in the periphery signal the vagus nerve, μ receptors 
may then play another role through the vagal nerve.  There are μ receptors present 
on vagal afferents that project to the NTS, which seem to influence cardiopulmonary 
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and gastrointestinal responses, resulting in a reduction in excitatory postsynaptic 
potentials through a calcium dependent mechanism (Atweh, Murrin, & Kuhar, 1978; 
Aicher, Goldberg, Sharma, & Pickel, 2000; Poole, Deuchars, Lewis, & Deuchars, 
2007; Rhim & Miller, 1994).  A reduction in excitation of the vagal nerve could also 
have the downstream effect of altering brain immune responses and sickness 
behaviors.   
 The final brain region involved in this proposed signaling pathway before 
reaching the hypothalamus is the locus coeruleus (LC), which could be affected by μ 
receptor activation through at least two potential mechanisms.  This region is well 
known for being the primary source of norepinephrine for the brain, as well as being 
intimately involved in the effects opiate withdrawal.  Acute opiates have an inhibitory 
effect on the LC, which is associated with μ receptors that are coupled with G 
protein-coupled inwardly-rectifying potassium (GIRK) channels (Christie, 1991; 
Torrecilla et al., 2002).  In addition to the μ receptors located within the LC, the 
periaqueductal gray (PAG), a region associated with opioid-induced analgesic 
effects and a large population of μ receptors, has inhibitory afferents to the LC, 
which could also inhibit the excitation of this region necessary for transmission of the 
autonomic signals received during an immune challenge (Aston-Jones et al., 1991).  
However, the action of the PAG has been linked only to suppression of natural killer 
cell activity in the spleen by morphine, which indicates this region may influence 
efferents from the central nervous system to the periphery as opposed to the 
afferents coming in from the periphery to the central nervous system that influence 
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production of proinflammatory mediators within the brain (Carr, Gebhardt, & Paul, 
1993).   
 There are many potential ways that heroin could influence brain 
proinflammatory mediators in the hypothalamus and subsequent fever production.  
Since this is the first time that the suppressive effect of heroin (or any opiate) on 
brain proinflammatory mediators has been shown in this manner, there are many 
possibilities for potential mechanisms.  Due to the influence of the hypothalamus on 
peripheral mechanisms, understanding brain proinflammatory activity may be of use 
to determine peripheral responses that are controlled by the central nervous system.  
Additionally, the “normal” pathways for immune activation by infection or other 
immune challenge is still controversial.  There is still much to be done in this area of 
interest.   
 
Connections between serotonin, hippocampus, activity, and immune 
activation  
 Unlike the hypothalamus and its role in fever, the role of the hippocampus in 
regulation of activity is not as commonly known amongst neuroscientists, and the 
interactions with proinflammatory mediators is even less known.  The pathway from 
peripheral inputs to the hippocampus is likely to be similar to that of the 
hypothalamus until the point of the NTS, and possibly the LC.  The connections to 
the hippocampus are too numerous and complex to enumerate here, although some 
discussion is necessary in light of the results found in this dissertation.  Although 
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very little research has been in regards to brain proinflammatory mediators and the 
hippocampus, we can learn about potential neurocircuitry involved by examining 
established connections from non-sickness behavior oriented perspectives.   
 Although the hippocampus is typically regarded as having a “learning and 
memory” function in neurobiology, this does not exclude the potential for other roles 
of this important brain region.  In particular, the serotonergic system and its 
connections in the hippocampus have been linked to the reduction in activity that is 
seen as a component of sickness behaviors.  Although often overlooked due to its 
many roles in other behaviors, the serotonin system is intricately involved in 
regulation of large muscle movements (as opposed to small, fine movements) 
(Jacobs et al., 1995).  Electrical activity in the hippocampus correlates strongly with 
gross movement such as walking and jumping, but not with small movements, such 
as licking or eating (Bland et al., 1972; Vanderwolf, 1969).  It has been proposed 
that the hippocampus, through serotonin, regulates gross motor movement, and the 
removal of the hippocampal control results in a dysregulation of movement control 
(Vanderwolf, 2001).  Disruption of electrical rhythms in the hippocampus causes a 
complete halt of those gross motor movements, and lesions of the hippocampus 
cause hyperactivity at first, and then hypoactivity, which is believed to be a result of 
an inability to control the “lower” motor regions (Vanderwolf, 2001; Vanderwolf, 
McLauchlin, Dringenberg, & Baker, 1997).  Under normal, non-immune activated 
conditions, serotonin positively correlates with activity (Linthorst et al., 1994; Jacobs 
et al., 1995).   
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During an immune challenge, however, activity decreases substantially while 
serotonin increases significantly (Linthorst et al., 1998; Linthorst et al., 1994).  
Immune challenge, then, appears to cause contradictory actions in the hippocampus 
regarding serotonin.  Increased serotonin is seen with peripheral LPS as well as with 
intrahippocampal IL-1β or LPS (Linthorst et al., 1998; Linthorst et al., 1994).  
Systemic IL-1β and IL-6 both cause increased serotonin in the hippocampus 
(Zalcman et al., 1994).  This is not to say that other neurotransmitters are not 
involved when an immune challenge as there are also moderate increases in 
norepinephrine, although not comparative to the increases in serotonin in the 
hippocampus or the increases of norepinephrine seen in the hypothalamus.  
Dopamine has also been shown to be increased as in some regions such as the 
prefrontal cortex, but is associated more with a generalized stress response than a 
specific immune response (Zalcman et al., 1994; Dunn, Wang, & Ando, 1999).   
Not only is serotonin increased with immune challenge, but proinflammatory 
mediators appear to increase serotonin.  In vitro studies have shown that the 
addition of a serotonin antagonist to lymphocyte and macrophage cultures causes a 
substantial decrease in IL-6 and TNF-α production (Kubera, Maes, Kenis, Kim, & 
Lason, 2005).  This is particularly interesting given that the results presented here in 
Chapter 4 indicated that IL-6 and TNF-α were the only two proinflammatory 
mediators in the hippocampus to be significantly increased with LPS/saline 
treatment and then decreased significantly in the heroin/LPS treated group.  As 
noted before, it was somewhat surprising that IL-1β did not show these effects, but 
the literature supports the idea that IL-6 might be more involved in hippocampal and 
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subsequent activity behavior, while IL-1β retains its well-supported role in 
hypothalamic actions and fever production.  This is corroborated by studies that 
show that IL-1β affects norepinephrine turnover and activation of hypothalamus, 
while IL-6, both peripheral and centrally administered, did not significantly increase 
norepinephrine turnover but did increase serotonin turnover in the brain, including 
the hippocampus (Wang et al., 1998; Zalcman et al., 1994).  IL-1β deficient mice 
also show impaired fever response to LPS, but still displayed a reduction in activity, 
indicating that IL-1β is vital to fever production but not may be as important to activity 
reduction during an immune challenge (Kozak et al., 1995).  Consistent with our 
results, IL-6 increases serotonin but does not necessitate PGE2 in order for effects 
mediated by serotonin to occur (Barkhudaryan et al., 1999).  
  
Potential mechanisms of opiates on immune-neural communication to the 
hippocampus 
 Norepinephrine is most implicated in hypothalamic activation and fever 
production, but serotonin is the neurotransmitter most likely to be primarily involved 
in the proinflammatory response in the hippocampus and subsequent behavioral 
depression.  Most serotonin in the brain originates from the raphe nuclei, which have 
a number of projections to other brain regions.  Specifically, the dorsal raphe 
nucleus (DRN) and median raphe nucleus (MRN) both contain primarily serotonergic 
neurons, but differ substantially in their projections and effects.  Both of these 
regions affect serotonin in the hippocampus, and may play differential roles in the 
motor regulation by the hippocampus and serotonergic transmission.  The MRN in 
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particular has been shown to be largely responsible for serotonin projections to the 
hippocampus, although some studies indicate that the MRN is largely involved in 
dorsal hippocampal function while the DRN is more involved in ventral hippocampal 
function (Coplan & Lydiard, 1998; Azmitia & Segal, 1978).  The output from the 
hippocampus to affect activity may include a number of brain regions, including the 
motor cortices, but also the subthalamic nucleus and posterior hypothalamus 
(Jacobs et al., 1995; Bland & Vanderwolf, 1972; Vanderwolf, 2001). 
 Unfortunately, since the hippocampal connections are so complex and little 
attention has been given to these connections in conjunction with opioid receptors 
and effects of opiates, it is difficult to speculate as much on potential mechanisms 
through which heroin might exert the immunosuppressive effects seen here on IL-6 
and TNF-α in the hippocampus.  The LC, as mentioned before, has a significant 
number of μ receptors, and also has noradrenergic projections to the hippocampus 
(Coplan et al., 1998).  However, given the relationship between serotonin and 
proinflammatory mediators in the hippocampus, particularly IL-6, it is less likely that 
noradrenergic projections are responsible for heroin’s immunosuppressive effects 
instead of serotonin.  The DRN, which is adjacent to the PAG, has inhibitory μ 
receptors on both GABAergic and glutamatergic neurons, which indicates that 
binding of these μ receptors could increase or decrease serotonin release from this 
area (Aghajanian & Sanders-Bush, 2002; Jolas & Aghajanian, 1997).  Additionally, µ 
receptors have been found in both the amygdala, which has projections to the 
hippocampus, and in the hippocampus itself (Mansour, Fox, Burke, Akil, & Watson, 
1995; Mansour, Fox, Thompson, Akil, & Watson, 1994). 
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 In short, due to the complexity of projections to and from the hippocampus in 
addition to the lack of research in this area specifically concerning sickness 
behavior, any suggestions of the pathways involved are preliminary at best.  
Certainly, there is a great deal of research potential in this area to determine the 
neuroimmune interactions involving the hippocampus that remains to be completed. 
 
Future directions and limitations of the current findings 
 The findings presented in this dissertation determined that heroin produces 
hyperthermia while not altering proinflammatory mediators by themselves, but when 
in the presence of an immune challenge (LPS), heroin has a suppressive effect on 
proinflammatory mediators in the hippocampus and hypothalamus in the brain, and 
thus also suppress associated sickness behaviors- behavioral depression and fever, 
respectively.  While I have proposed potential pathways for these interactions in the 
General Discussion, experiments in this dissertation did not aim to determine the 
pathways through which opiates may exert these effects.  Experiments designed to 
address potential pathways for neuroimmune interactions with opiates will, hopefully, 
be done in the future.    
 There are a few limitations of the experiments presented in this dissertation 
that should be acknowledged.  The experiments were designed specifically to 
measure mRNA of proinflammatory mediators.  The only protein measured in these 
studies was β-endorphin, which was done because β-endorphin is cleaved from 
POMC, and the transcription of POMC does not necessarily indicate that β-
endorphin levels as a number of other proteins are also derived from POMC.  The 
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measurement of mRNA of proinflammatory mediators is both a strength and 
limitation.  By using mRNA as the measure, I have established that cells are in the 
process of producing these proinflammatory mediators.  While our RNA extraction 
method allows for site-specific (i.e., hypothalamus versus hippocampus) extractions, 
it does not allow us to determine the cellular origin of the proinflammatory mediator 
mRNA (i.e., microglia versus neuron).  Additionally, not everything that is being 
upregulated in mRNA in the cell necessarily makes it to fully-formed protein, nor 
does it necessarily get secreted by the cells.  This could be remedied by also 
measuring protein.  Unfortunately, due to the low amounts of protein in brain tissue, 
it would be difficult if not impossible to measure protein and mRNA from the same 
animals.  To confirm that protein is produced and biologically active, a number of 
assays could be used, including Western blot or enzyme linked immunosorbent 
assays (ELISAs), although this would require an entirely new series of experiments 
independent of mRNA results.  However, unlike the mRNA results, protein results 
cannot determine where the proinflammatory mediators originated- for example, 
protein could indicate that proinflammatory mediators are increased, but it cannot 
determine if those mediators were produced from cells in the hypothalamus or if the 
proteins were synthesized in the periphery and crossed the blood brain barrier. 
 Another limitation that should be mentioned is that these experiments are 
observations of proinflammatory mediators during LPS and/or heroin treatment as 
opposed to the manipulation of a specific molecule.  For instance, a follow up study 
would be ideal to determine my proposed role of IL-6 in the hippocampus as it 
relates to a reduction in activity.  One potential follow up to the studies presented 
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here would be to inject IL-6 antibodies into the hippocampus after LPS 
administration to see if the reduction in activity could be blocked in this manner.  
This kind of thinking could be carried out on various proinflammatory mediators in 
both activity and fever behaviors in the hippocampus and the hypothalamus, 
although some of this work has been done previously in the hypothalamus with 
mixed results.  One must be cautious regarding injections involving cannulations into 
the brain due to inflammatory reactions that typically surround the cannula for man 
weeks post-surgery- this would make measuring or manipulating proinflammatory 
mediators in the specific region problematic when the baseline has already been 
disrupted (Holguin et al., 2007).   
 The acute hyperthermia that opiates such as heroin are have been shown in 
the literature to be μ receptor mediated, and is likely to be caused directly by μ 
receptors on temperature sensitive and insensitive neurons in the hypothalamus.  
Short of showing directly that μ receptors are activated in the hypothalamus during 
hyperthermia, in vivo work is limited at this point in time until this is possible to do in 
a live organism.  However, the technology to determine μ receptor activation is 
possible for in vitro work, and this could be a potential avenue of research to further 
the determination of heroin-induced hyperthermia.   
 The latter two chapters (Chapters 3 and 4) of this dissertation addressed the 
peripheral immune challenge of LPS in conjunction with heroin administration.  The 
pathways proposed in the General Discussion section are specific for events which 
begin with a peripheral immune challenge, such as in the studies presented in this 
dissertation that utilize subcutaneously administered LPS.  While these are perhaps 
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more clinically relevant (i.e., most infections begin in the periphery), there are other 
ways to induce an immune response in the brain.  There are numerous studies that 
show that LPS or other immune challenges injected directly into the brain, either 
site-specifically or into the ventricles, also causes an inflammatory response in the 
brain (Aid, Langenbach, & Bosetti, 2008).  Obviously, this type of immune activation 
is unlikely to begin with peripheral immune cells, or even spinal responses.  Injection 
of LPS directly into the brain would help elucidate neural pathways and localize key 
regions involved in these processes, particularly if neurotransmitters could be 
specifically measured or manipulated.   
 The relationship between neurotransmitters and cytokines is one that is at 
best still poorly understood, and much work remains to be done in this area.  Future 
studies that examine both cytokine and neurotransmitters in the same experiment 
would be of use to determine the neuroimmune pathways I have proposed in this 
dissertation.  For instance, to determine the role of norepinephrine in the 
communication between the peripheral immune system and the central immune 
reaction, I would propose the completion of a series of studies that site-specifically 
antagonized norepinephrine in the brain regions proposed to be involved in the 
communication:  NTS, LC, and hypothalamus and/or hippocampus.  Systemic 
blockade of norepinephrine has already been shown to attenuate neuroinflammatory 
events in the hippocampus and cortex, but the addition of site-specific antagonism 
would contribute a great deal to understanding the particular brain regions involved 
(O'Sullivan, Ryan, Curtin, Harkin, & Connor, 2009; Szelenyi & Vizi, 2007).  Since 
there seems to be contradictory evidence regarding the necessity of norepinephrine 
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in the hippocampus for sickness-related reduction in activity, it would be worthwhile 
to measure serotonin, through microdialysis or other molecular techniques, while 
site-specifically antagonizing norepinephrine to determine whether norepinephrine 
influences serotonin or if these actions are separate in this paradigm.  Similarly, 
performing site-specific injections of antagonists for serotonin during an immune 
challenge would further elucidate the role of this neurotransmitter in the 
neuroimmune pathway, particularly as it relates to behavioral depression.   
 To further examine the mechanisms of how heroin produces 
immunosuppression in the brain and suppresses sickness behaviors, I would 
propose the use of site specific μ agonists to determine which brain regions appear 
to have the most control over heroin-induced immunosuppression in the brain.  As 
listed above, there are many brain regions associated with μ receptors, including the 
LC and PAG regions.  These regions would likely be the first to be examined in 
these types of studies.  Since endogenous opiates may also play a role in regulating 
normal immune responses to LPS and other infections, it may also be of interest to 
use μ receptor antagonists to see if it is possible to potentiate the immune response 
to LPS.  Likewise, although the μ receptor is the most obvious choice for heroin 
treatment to directly affect, κ and δ opioid receptors should also be examined for 
potential modulation of central immune responses.  Since all of these proposed 
studies are aimed at attempting to delineate pathways in the neuroimmune response 
and potential effects of opiates, the use of knockout or transgenic animals would be 
unlikely to provide much benefit, unless those genetically altered animals are 
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conditional knockouts and/or restricted to a particular region or cell type (i.e., 
macrophages lacking μ receptors).   
 
Conclusion 
 In conclusion, the data presented in this dissertation are exciting evidence 
contributing to our knowledge of neuroinflammatory events and sickness behavior, 
and the first to indicate that opiates – specifically, heroin- affect proinflammatory 
mediators in the brain.  We demonstrated that heroin produces a proinflammatory 
mediator-independent hyperthermia.  Furthermore, heroin suppressed all measured 
proinflammatory mediators in the hypothalamus as well as two key proinflammatory 
cytokines, IL-6 and TNF-α, in the hippocampus.  Heroin also attenuated the sickness 
behaviors of fever, which is associated with the hypothalamus, and behavioral 
depression, which is associated with the hippocampus.    
 These results lay the groundwork for future studies to examine the 
relationships between proinflammatory mediators, specific brain regions, sickness 
behaviors, and opiates.  The experiments in this dissertation are designed to 
establish the effects of opiates in general on proinflammatory mediators and 
sickness behaviors.  These experiments have accomplished this goal, but it should 
be noted that the relationship between the proinflammatory mediators in the specific 
brain regions is correlational at best with the sickness behaviors exhibited.  Now that 
the effects of heroin on proinflammatory mediators and sickness behavior have been 
demonstrated, future studies should focus on determining causation for the many 
factors that are still undetermined: brain region circuitry and pathways in the 
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neuroimmune communication, interactions between proinflammatory mediators and 
neurotransmitters, and potential localization and specific effects of µ agonist action.  
There remains much work to be done in this field but the observations reported here 
are the first steps in understanding the complex interactions of neuroimmune 
responses and associated behaviors with opiates.   
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